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ABSTRACT OF DISSERTATION 
 
 
 
 
MULTIMODAL NONCONTACT DIFFUSE OPTICAL REFLECTANCE IMAGING 
OF BLOOD FLOW AND FLUORESCENCE CONTRASTS 
 
In this study we design a succession of three increasingly adept diffuse optical 
devices towards the simultaneous 3D imaging of blood flow and fluorescence 
contrasts in relatively deep tissues. These metrics together can provide future 
insights into the relationship between blood flow distributions and fluorescent or 
fluorescently tagged agents. A noncontact diffuse correlation tomography (ncDCT) 
device was firstly developed to recover flow by mechanically scanning a lens-
based apparatus across the sample. The novel flow reconstruction technique and 
measuring boundary curvature were advanced in tandem. The establishment of 
CCD camera detection with a high sampling density and flow recovery by speckle 
contrast followed with the next instrument, termed speckle contrast diffuse 
correlation tomography (scDCT). In scDCT, an optical switch sequenced coherent 
near-infrared light into contact-based source fibers around the sample surface. A 
fully noncontact reflectance mode device finalized improvements by combining 
noncontact scDCT (nc_scDCT) and diffuse fluorescence tomography (DFT) 
techniques. In the combined device, a galvo-mirror directed polarized light to the 
sample surface. Filters and a cross polarizer in stackable tubes promoted 
extracting flow indices, absorption coefficients, and fluorescence concentrations 
(indocyanine green, ICG). The scDCT instrumentation was validated through 
detection of a cubical solid tissue-like phantom heterogeneity beneath a liquid 
phantom (background) surface where recovery of its center and dimensions 
agreed with the known values. The combined nc_scDCT/DFT identified both a 
cubical solid phantom and a tube of stepwise varying ICG concentration 
(absorption and fluorescence contrast). The tube imaged by nc_scDCT/DFT 
exhibited expected trends in absorption and fluorescence. The tube shape, 
orientation, and localization were recovered in general agreement with actuality. 
The flow heterogeneity localization was successfully extracted and its average 
relative flow values in agreement with previous studies. Increasing ICG 
concentrations induced notable disturbances in the tube region (≥ 0.25 μM/1 μM 
for 785 nm/830 nm) suggesting the graduating absorption (320% increase at 785 
nm) introduced errors. We observe that 830 nm is lower in the ICG absorption 
  
spectrum and the correspondingly measured flow encountered less influence than 
785 nm. From these results we anticipate the best practice in future studies to be 
utilization of a laser source with wavelength in a low region of the ICG absorption 
spectrum (e.g., 830 nm) or to only monitor flow prior to ICG injection or post-
clearance. In addition, ncDCT was initially tested in a mouse tumor model to 
examine tumor size and averaged flow changes over a four-day interval. The next 
steps in forwarding the combined device development include the straightforward 
automation of data acquisition and filter rotation and applying it to in vivo tumor 
studies. These animal/clinical models may seek information such as simultaneous 
detection of tumor flow, fluorescence, and absorption contrasts or analyzing the 
relationship between variably sized fluorescently tagged nanoparticles and their 
tumor deposition relationship to flow distributions. 
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Noncontact Diffuse Correlation Tomography (ncDCT), Blood Flow, 
  Fluorescence, Multimodal Imaging 
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CHAPTER 1 INTRODUCTION 
 
1.1 Blood Flow and Fluorescence in Cancer Research 
 
Blood flow and its response to physiological changes can serve as a status 
indicator into underlying tissue microenvironment conditions. Many diseased and 
abnormal progressions manifest through functional presentation as well as, or 
even prior to, observable structural alterations. Thus, monitoring the blood flow can 
provide supporting information to medical professionals in the detection, diagnosis, 
and treatment of patients. It may also serve in early studies on small animals which 
seek to gain, for example, insights into disease mechanisms and the effectiveness 
of treatments. One of the most prevalent objectives in flow studies is then to 
observe the contrast in flow between healthy and abnormal tissues which can help 
characterize diseases such as cancer.  
Specifically, the microenvironment of cancerous tissues is distinguishable from 
healthy tissues by its highly irregular and chaotic vascular network. The feature of 
induced angiogenesis has been identified as one of the hallmarks of cancer [1]. 
How this overarching observation originates and presents in specific cases varies 
widely. A summarization of reported intertumoral blood flows in human 
malignancies and healthy tissues highlights upon the disparities; for example, 
squamous cell carcinoma breast cancer blood flow was found to range from ~0.07 
– 0.40 ml/g/min compared to the mean healthy lactating and post-menopausal 
breast of 0.80 and 0.04 ml/g/min respectively [2]. The linking of increased 
angiogenesis and blood flow has been reported [3, 4]. Furthermore, tumor 
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vascularity as evaluated by mean arteriole number has been shown to exhibit a 3-
fold increase in carcinomas [4]. Intratumoral variations frequently occur due to the 
unregulated growth and cellular proliferation accompanied by other 
microenvironmental alterations. Hypoxic and necrotic tissue regions can form in 
unpredictable fashion as nutrient transport is inhibited by perfunctory vessel 
networks and the collapse of vessels due to rising interstitial pressures [2]. 
Fluorescing agents also play a role of great medical interest, especially in 
cancer studies. One of the biggest impediments to cancer treatment is the ability 
to penetrate and effectively deliver drugs or other factors throughout a solid tumor. 
Adequate drug delivery and targeting of tumor tissues then largely governs 
treatment success [5-10]. Some studies rely on the enhanced permeability and 
retention (EPR) effect [11]. The injection of drugs is expected under EPR 
circumstances to preferentially accumulate in the leaky tumor vasculature. This 
behavior is extended to the injection of fluorescent agents for localizing in and 
demarcating tumor tissues. Though useful, the EPR assumption is not ideal and 
much current research into increasing control has taken the direction of 
nanotechnology, including the labeling of nanoparticles with fluorescence [12]. 
Nanoparticles provide a robust framework for leveraging receptor targeting, 
polymorphic adaptations, and drug loading and are expected to become an 
essential part of cancer therapy. It is anticipated that multipurpose nanoparticle 
designs can tailor treatments in innovative ways to the unique features of different 
cancers, location, and subject.  
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1.2 Medical Imaging and Diffuse Optics 
 
Contemporary medical imaging options are numerous as is evinced by 
perusing any modern healthcare facilities’ list of imaging services. These may be 
practically differentiated by the nature of their probe such as acoustic waves 
(Ultrasound, Doppler Ultrasound) and electromagnetic radiation as x-rays 
(Projection Radiography, Mammography, Computed Tomography, Fluoroscopy), 
visible light (Optical Coherence Tomography, Laser Speckle Contrast Imaging, 
Laser Doppler), radiofrequency (Magnetic Resonance Imaging, Functional 
Magnetic Resonance Imaging/Blood-Oxygen-Level Dependent Contrast Imaging, 
Magnetic Resonance Angiography), and injectable emitters of gamma rays 
(nuclear imaging; Positron Emission Tomography, Stimulated Positron Emission 
Computed Tomography). The latitudes in making an appropriate selection depend 
on many factors including the type of information recoverable, tissue type 
applicability (i.e., brain, muscle), safety, hardware and operating costs, and time 
and convenience (i.e., image acquisition duration, real-time vs. delayed results). 
Near-infrared (NIR; 650-900 nm) light has gained growing contemporary popularity 
among medical imaging modalities with its clinically preferential safety (e.g., 
nonionizing radiation), noninvasiveness, sensitivity to physiological processes in 
deep tissues (several centimeters), relative low cost in the realm of clinical imaging 
instrumentation, and potential for portable bedside measurements. 
Advances over the last two centuries have set the foundation for modern NIR 
optics and tomography including the development of appropriate theories and 
observations (i.e., statistical physics, wave-particle duality, radiative transfer), and 
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available tools/technology (i.e., fast and efficient algorithms, modeling software, 
computing resources, lasers, sensitive light detectors). Less than two decades 
after the advent of the laser around 1960, an “NIR Window” (Figure 1.1) was 
distinguished (though recognition of optical transmission in tissue existed prior 
[13]) whereby biological tissues present low optical absorption and high scattering 
allowing measurement of oxygenated hemoglobin and deoxygenated hemoglobin 
concentrations (tissue oxygenation) [14]. The current diffuse optical 
instrumentation stemming from this collective keystone are diverse. Systems may 
be separated by use of continuous-wave (CW; intensity), frequency-domain (FD; 
amplitude and phase), or time-domain (TD; temporal point spread function) 
paradigms which inherently envelopes their measurables and dictates system 
design. Prioritizing transillumination or reflectance signals further dichotomizes 
their suitable applications. The systems may focus on spectroscopy or imaging, 
the latter typically the most desirable and consequently complex. 
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Figure 1.1: The near-infrared window. The molar extinction coefficient 
demonstrates low light absorption characteristics of the common intrinsic 
absorbing tissue chromophores: oxygenated hemoglobin, HbO2, and 
deoxygenated hemoglobin, Hb. 
 
The properties of light in the NIR spectrum and its interactions with biological 
tissues offer many options for extracting useful information depending on the 
particular feature of light and type of tissue such as angiogenesis, biochemical 
information, metabolism, and scatterer size distributions [14, 15]. In this study, we 
restrict ourselves to CW systems which are the simplest and most economical 
paradigm. We incorporate three diffuse optical imaging modalities capable of 
extracting unique sets of information, namely diffuse optical spectroscopy and 
tomography (DOS/DOT) for absorption, diffuse fluorescence spectroscopy and 
tomography (DFS/DFT; also known as diffuse optical fluorescence tomography 
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DOFT) for fluorophore concentration, and diffuse correlation spectroscopy and 
tomography (DCS/DCT) for blood flow changes. 
These diffuse optical techniques have proven successful in cancer research 
investigations. For example, absorption contrasts, enhanced by indocyanine green 
(ICG) and measured by DOT, identified cancerous tissues (e.g., ductal carcinoma, 
fibroadenoma) and a non-specific heterogeneous distribution for healthy tissues 
(e.g., no disease) in the human breast [16]. These results were validated against 
Gadolinium (Gd)-enhanced MRI images. The fluorescent signal contrasts of ICG 
have also been measured by DFT in separating healthy and diseased human 
breast tissues (e.g., invasive carcinomas), validated against Gd-enhanced MRI 
[17]. Sufficient temporal resolution enables using absorption and/or concentration 
information to examine the ICG pharmacokinetics [18]. The simultaneous 
monitoring of absorption and fluorescence changes has already been methodically 
compared to determine the optimal acquisition arrangement (under FD 
considerations) [19]. A DCT-based device, validated by ultrasound (US), exhibited 
that it too has the potential to differentiate healthy and abnormal breast tissues 
(e.g., ductal papilloma and low-grade adenocarcinoma, atypical ductal hyperplasia 
and low-grade carcinoma) through presentations of blood flow heterogeneities 
[20]. The combination of tissue hemodynamic parameters as recovered by diffuse 
optical methods was furthermore deemed beneficial in predicting radiation therapy 
outcome in a recent head-neck tumor study [21]. 
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1.3 Diffuse Optical Spectroscopy and Tomography (DOS/DOT) 
 
The DOS/DOT technique often relies on the photon diffusion equation (PDE) 
which we make use of to extract tissue absorption information and derive a flow 
reconstruction method. The photon diffusion equation is defined with a continuous 
wave (𝜔 = 0) source for the photon fluence rate Φ(𝒓) (W/cm2) as [15]: 
 
 [∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎(𝒓)]Φ(𝒓) = −𝑣𝑆(𝒓) (1.1) 
 
with position vector 𝒓 (cm), tissue absorption coefficient 𝜇𝑎(𝒓) (cm
-1), speed of light 
in the medium 𝑣 (cm/s), photon diffusion coefficient 𝐷 ≈ 𝑣/3𝜇𝑠
′(𝒓) where 𝜇𝑠
′(𝒓) (cm-
1) is the reduced scattering coefficient, and isotropic source term 𝑆(𝒓) (W/cm3). 
Unless required for clarity the spatial dependence of the optical properties (𝜇𝑎, 𝜇𝑠
′ ) 
will not be explicitly noted at every reference. The optical properties also exhibit a 
wavelength (𝜆) dependence which will be identified if context demands. 
DOS/DOT techniques have been used in the monitoring and imaging of the 
reduced scattering coefficient, oxygenated and deoxygenated hemoglobin 
concentration, and oxygen saturation in addition to the absorption coefficient [22-
27]. The absorption coefficient is related to chromophore concentrations as 
𝜇𝑎(𝜆) = ∑ 𝜖𝑖(𝜆)[𝐶𝑖]
𝑚
𝑖=1  where 𝜖𝑖 and [𝐶𝑖] are the 𝑖
𝑡ℎ chromophore’s molar extinction 
and concentration, respectively. We do not evaluate chromophore contents in this 
study, but the primary biological absorber (wavelength dependent) in most tissues 
is hemoglobin with other minor contributors such as water varying in concentration 
with tissue type and composition. Using our CW system, we herein monitor 
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changes in the absorption coefficient 𝜇𝑎(𝒓) (cm
-1) only. The extension of the 
spectroscopic application to tomography follows the finite element method (FEM) 
implementation as described in Chapter 4. 
 
1.4 Diffuse Fluorescence Spectroscopy and Tomography (DFS/DFT) 
 
DFS/DFT establishes a set of coupled equations linking the diffusive 
propagation of the excitation light to the diffusive propagation of the 
emitted/fluoresced light. This is used to recover sample fluorescence changes and 
is commonly applied in cancer research [16, 17, 19, 28-37]. The fluorescence 
photon fluence Φ𝑓𝑙(𝒓) is described by (with CW) [17, 38]: 
 
 [∇ ∙ 𝐷𝑒𝑥(𝒓)∇ − 𝑣𝜇𝑎,𝑒𝑥(𝒓)]Φ𝑒𝑥(𝒓) = −𝑣𝑆(𝒓) (1.2) 
 [∇ ∙ 𝐷𝑓𝑙(𝒓)∇ − 𝑣𝜇𝑎,𝑓𝑙(𝒓)]Φ𝑓𝑙(𝒓) = −(𝜂𝜖𝑒𝑥[𝑁])Φ𝑒𝑥(𝒓) (1.3) 
 
with excitation and emission parameters subscripted with ex and fl respectively, 
the fluorescence quantum yield 𝜂, fluorophore extinction coefficient 𝜖𝑒𝑥, and the 
fluorophore concentration [𝑁]. The absorption coefficients here are contributed to 
by both endogenous chromophores and exogenous fluorophores. From Equation 
1.3 the RHS can be seen to be the solution to Equation 1.2 modified by the 
fluorescence properties and concentration. The fluorescence yield, 𝜂𝜖𝑒𝑥[𝑁] =
𝜂𝜇𝑎,𝑓𝑙, is the parameter commonly resolved in practice and its relative change 
monitored. If 𝜂 and 𝜖𝑒𝑥 are known, then the absolute concentration can be 
separated. In this study, we monitor relative changes in the fluorescent yield as 
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produced by the addition of the exogenous ICG fluorescent agent. Tomography is 
implemented within the FEM framework in a manner similar to DOT and is also 
described in Chapter 4.  
 
1.5 Diffuse Correlation Spectroscopy and Tomography (DCS/DCT) 
 
DCS/DCT theory is provided by an analogous correlation diffusion equation 
(CDE) to the PDE which models the diffusive propagation of the unnormalized 
temporal electric field correlation function 𝐺1(𝒓, 𝜏) = 〈𝐸(𝒓, 𝑡)𝐸
∗(𝒓, 𝑡 + 𝜏)〉 in 
biological tissues. Fluctuations in this electric field enable detection of the 
underlying flow processes and DCS/DCT has been used in many applications 
including muscle, brain, and cancer as mentioned earlier [20, 21, 39-62]. The CDE 
is defined by  [63]: 
 
 [∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎(𝒓) −
1
3
𝛼𝑣𝜇𝑠
′(𝒓)𝑘0
2〈∆𝑟2(𝒓, 𝜏)〉] G1(𝒓, 𝜏) = −𝑣𝑆(𝒓) (1.4) 
 
with autocorrelation decay time 𝜏 (s) and wavenumber 𝑘0. The mean-square 
displacement (MSD) 〈∆𝑟2(𝒓, 𝜏)〉 describes the motion of scattering particles (e.g., 
primarily moving red blood cells in tissues or Intralipid® emulsions in phantoms) in 
time 𝜏. Another factor, 𝛼, accounts for the generally unknown ratio (between 0 and 
1) of moving to total scatterers. In practice, we approximate a collimated source as 
a diffuse point source one scattering distance into the sample, 1/𝜇𝑠
′  [64]. 
The solution to Equation 1.4 for semi-infinite geometry provides the form of 𝐺1 
encountered on media such as the slabs used in experimental phantoms and as 
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an approximation on many real tissues. The corresponding semi-infinite solutions 
to Equations 1.1 – 1.3 are of similar form and can be found elsewhere [22, 38]. 
The semi-infinite solution for 𝐺1 is [65]: 
 
 G1(𝜌, 𝜏) =
𝑣𝑆0
4𝜋𝐷
[
exp(−𝑟1𝑀)
𝑟1
−
exp(−𝑟2𝑀)
𝑟2
] (1.5) 
 
where 𝑀2 = 3𝜇𝑎𝜇𝑠
′ + 𝜇𝑠
′ 2𝑘0
2𝛼〈∆𝑟2(𝜏)〉, 𝑟1 = √𝜌2 + (𝑧 − 𝑧0)2, 𝑧0 = 1/𝜇𝑠
′ , 𝑟2 =
√𝜌2 + (𝑧 + 𝑧0 + 2𝑧𝑏)2, 𝑧𝑏 = 2(1 + 𝑅𝑒𝑓𝑓) /3𝜇𝑠
′(1 − 𝑅𝑒𝑓𝑓), 𝑅𝑒𝑓𝑓 = −1.440𝑛
−2 +
0.710𝑛−1 + 0.0636𝑛 + 0.668 accounts for the refractive index mismatch between 
air and the medium, 𝑛 ≈ 1.33 for tissues and tissue-like phantoms, 𝜌 = |𝒓 − 𝒓𝑠| is 
the source-detector (SD) separation with source position 𝒓𝑠 on the sample surface, 
and 𝑆0 is the source term. The MSD in tissues is often modeled by Brownian motion 
where 〈∆𝑟2(𝜏)〉 = 6𝜏𝐷𝐵 with the effective diffusion coefficient of moving scatterers 
𝐷𝐵. The 𝛼𝐷𝐵 term is collectively referred to as the blood flow index, 𝐵𝐹𝐼, which has 
been validated against multiple modalities including laser Doppler flowmetry [66, 
67], Doppler ultrasound [68, 69], power spectral Doppler ultrasound [60], Xenon 
CT [70], arterial-spin-labeled MRI [71], and fluorescent microsphere flow 
measurement [72]. 
A single semi-infinite DCS measurement typically collects the normalized 
intensity autocorrelation function, 𝑔2(𝜌), at a specific SD position 𝜌 by hardware or 
software correlator processing of avalanche photodiode (APD) photon counts at 
multiple correlation times. This function can be fit to the normalized 𝑔1(𝜌, 0) of 
Equation 1.5 for quantifying 𝛼𝐷𝐵. The Siegert relationship 𝑔2(𝜏) = 1 + 𝛽|𝑔1(𝜏)|
2 
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can relate the intensity (measured) and electric field (model) autocorrelation 
functions where 𝛽 is subject to the speckle and collection optics [73]. Fitting the 
curve for 𝐵𝐹𝐼 and 𝛽 simultaneously has been shown to improve results [74]. 
Optical fiber selection impact on DCS and other diffuse technologies has also been 
reported [75]. We use a novel FEM flow reconstruction method for imaging based 
on the PDE implementation, outlined in detail in Chapter 2. 
 
1.6 Current Limitations and Thesis Outline 
 
It is foreseen that a new single imaging instrument divulging both blood flow 
and fluorescence distributions in deep tissues is both necessary and desired to 
push forward into new potential research investigations. In a recent study, a 
relationship between tumor blood flow and nanoparticle deposition according to 
liposome size was found [76]. Thus, the 3D imaging of crucial detailed information 
about tumor tissue microvasculature and fluorescently-tagged nanoparticle spatial 
heterogeneity may significantly enhance realizable treatment efficacy of drug 
delivering nanoparticles. That study exemplifies the potential new facets of cancer 
research and highlights the difficulties. Imaging was performed with both dynamic 
contrast-enhanced computed tomography (DCE-CT) and fluorescence molecular 
tomography (FMT) requiring manual co-registration, landmark fiducials, and 
carefully interpreting the data acquired separately. 
An instrument is thus proposed based on diffuse optical methods with 
multimodal flow and fluorescence capabilities. It will perform medical investigations 
within the NIR paradigm of diffuse optics, be relatively low cost and portable, have 
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robust sampling density and time, and obviate co-registration and related 
complications. Further desirables will include constraints that it be noncontact to 
avoid hemodynamic alterations [77-79] and reflectance-mode operation for 
translatability across subjects of varying sizes (i.e., small animals to humans). It 
would additionally be expandable to measure absorption and related derivatives. 
The extension of diffuse optical spectroscopies to tomographic imaging has 
brought with it an ascension in multimodal imaging opportunities. Despite 
extensive progress, there has been an absence of a device which aggregated all 
the proposed features. Specifically, a fully noncontact multimodal diffuse optical 
instrument employed in reflectance-mode for the gathering of flow and 
fluorescence 3D distributions has yet been missing in the field. The development 
of such an instrument is the primary objective of this dissertation. The facilitation 
of a fully noncontact system requires moving the source and detection elements 
away from the tissue surface. Noncontact DOT/DFT systems have been previously 
developed using CCD cameras away from the interface [80-83]. No such systems 
have yet combined a reflectance design with CCD-based deep tissue flow imaging. 
This absent solution is due in part to the lack in developments of the latter. 
Early DCT implementations have relied on the monitoring of light by high 
temporal resolution APD’s to establish a correlation curve to fit the theoretical 
solution (Equation 1.5) [63, 84-86]. This type of detection element can be 
restrictive in its cost, scaling to high density sampling, and physical space 
overhead. As an alternative, CCD camera’s offer a cost-effective solution to these 
limitations. CCD detection for flow imaging has already been employed abundantly 
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in techniques such as laser speckle contrast imaging (LSCI) [87, 88]. In 
comparison to our objectives, LSCI methods are largely used to probe superficial 
vascular distributions (up to 1 mm depth) with a wide-field illuminated light source 
[89, 90]. The extension of speckle contrast to the monitoring and imaging of deep 
tissues has been explored by several groups recently and replace the wide-field 
illumination with a point-like light source. The approach of diffuse speckle contrast 
analysis (DSCA) is to directly monitor inverse speckle contrast variations as a 
measure of the proportional change with the DCS 𝐵𝐹𝐼 in the range of typical tissue 
properties [91-93]. Speckle contrast optical spectroscopy (SCOS) and tomography 
(SCOT) have been developed relating the speckle contrast parameter and DCS 
theory [94, 95]. The SCOT imaging uses perturbation and the Born approximation 
to establish the sensitivity relationship between changes in flow dynamics directly 
to speckle contrast and was tested in the transmission mode.  
As mentioned in Chapter 1.5 we have developed a novel flow reconstruction 
method. In our approach to CCD-based speckle contrast flow imaging, we retain 
our flow reconstruction advantages while deriving a link between it and speckle 
contrast flow measurements. This leverages our inherited reconstruction benefits 
from DOT developments due to the CDE/PDE equation and solution similarities 
while also accomplishing the utilization of a CCD camera for light detection of 
speckle contrasts. The speckle contrasts can be converted to boundary 𝐵𝐹𝐼 which 
can then be input into the established FEM-based reconstructions and thereby 
amalgamate the robustness of CCD detection and previous/future flow imaging 
advancements. 
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Combining these advances with a noncontact light source and established 
DOT/DFT techniques, we expect that the resulting pioneered completely 
noncontact CCD-based system will synergize the benefits of all and provide a 
powerful new imaging technique for cancer research. In this study we incorporate 
the necessary theoretical advancements, hardware and software modifications, 
and preliminary testing to instantiate the highly translatable noninvasive imaging 
device that will serve as a robust segue between animal and human/clinical 
studies. This new technique allows for an accessible multiparameter data set 
without the complexities of image coregistration and multiple instrumentation data 
acquisition. The potential applications of this new device include the in vivo 
characterization of tumor detection and growth by flow distributions and those of 
ICG as well as opening the analysis on the relationship between fluorescently-
tagged nanoparticles of varied size and localized flow differences. 
The chapter outline of this thesis is as follows. The instrumentation is 
progressively developed in three stages: noncontact diffuse correlation 
tomography (ncDCT), speckle contrast diffuse correlation tomography (scDCT), 
and noncontact speckle contrast diffuse correlation tomography and diffuse 
fluorescence tomography (nc_scDCT/DFT). Chapter 2 describes the ncDCT flow 
imaging instrumentation, complex boundary acquisition, our flow reconstruction 
method, and provides the results of a case study of ncDCT application on small 
animal tumors. Chapter 3 presents the derived theoretical relationship between 
diffuse speckle contrast and the normalized temporal autocorrelation function and 
the modified instrumentation for CCD-based detection, termed scDCT, and its 
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phantom validation. Chapter 4 follows with the multimodal reflectance-based 
nc_scDCT/DFT device prototype and its experimental validation. All personal 
contributions are more specifically relayed, along with overall study limitations and 
perspectives, in the closing Chapter 5. 
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CHAPTER 2 NONCONTACT DIFFUSE CORRELATION TOMOGRAPHY 
 
2.1 Introduction 
 
ncDCT serves as our flow imaging instrumentation progenitor and the 
foundational methodology upon which advancements are made in the following 
chapters. The novelty of ncDCT can be conceptualized as the straightforward 
transition from its stationary predecessor, noncontact diffuse correlation 
spectroscopy (ncDCS), to enable noncontact flow imaging. Accomplishing this 
goal thereby inherits the benefits of being noncontact and reflectance mode. 
ncDCS has been evaluated in simulations, tissue-like phantoms, forearm tissue 
cuff occlusions and head and neck cancer free tissue transfer flaps [96-98]. The 
ncDCT methods outlined in this chapter have been tested in simulations, 
phantoms, and real tissues including human breast tumor [20, 85, 99-101]. 
In this chapter we begin by examining the ncDCT hardware specifications and 
operation. An understanding of this implementation highlights the importance of 
our modifications in later chapters. Measuring and incorporating complex 
boundaries and finding source and detector surface coordinates is addressed for 
completeness. While a necessity in many real tissue encounters, this task is 
comparatively negligible in simple phantom models. Next are details of the FEM 
flow reconstruction method. This method is utilized throughout the thesis for flow 
reconstructions. As it is based on readily available open source software 
(NIRFAST, Dartmouth College, NH), seamless integration of geometries and 
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inversion algorithm techniques is promoted. The chapter will conclude with the 
application of ncDCT to an in-vivo mouse tumor study. 
 
2.2 Instrumentation 
 
A lens-based focusing apparatus suspended from a boom arm orchestrates 
the collection of boundary flow measurements (Figure 2.1) [20, 85, 97, 98]. The 
apparatus bookends a linear array of 15 single-mode detector fibers (SM800-5.6-
125, Fibercore, CA) with 2 multimode source fibers (WF200/220/245, 
CeramOptec, MA) allowing for a 10 – 30 mm SD range and separate source and 
detector paths. The source paths consisted of two lenses (each) to collimate then 
focus the source light onto the sample surface. The detector path guided 
collimated light onto detector fiber tips after having passed through a 750 nm long-
pass filter (FEL0750, ThorLabs, NJ) and aperture upon collection by an achromatic 
focusing lens. Detector fibers were connected to a bank of avalanche photodiodes 
(PerkinElmer, Canada). The APD intensity autocorrelation functions were 
simultaneously and dynamically processed by a multiple channel autocorrelator 
(Correlator.com, NJ). Each source fiber connected to an 830 nm long coherence 
laser (coherence length > 5 m; CrystaLaser, NV). A linear (T-LSM200A, Zaber, 
Canada; 5236A16, McMaster-Carr, IL) or rotational (CR1-Z7, Thorlabs, NJ) stager 
impressed mechanical translations to scan an ROI with an adjustable step size. 
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Figure 2.1: ncDCT instrumentation. The (a) lens-based focusing apparatus is 
positioned above a sample and scans over an ROI through mechanical translation 
to acquire a set of boundary flow data. (b) Light is projected by two individual 
source paths and collected by a linear array of detector fibers. (c) A single scan 
step provides SD separations from 10 – 30 mm for each of the two separate 
sources. 
 
2.3 Complex Boundary Acquisition and Source/Detector Placement 
 
The FEM reconstruction requires the incorporation of a finite element mesh 
representative of the sample and the surface coordinates of source and detector 
positions. In the simplest cases we may form a mesh from simple geometries such 
as a slab with built-in NIRFAST functionality and use the straightforward SD 
projections on a flat surface. In the case of real tissues, we aren’t gifted with such 
ideal circumstances and use more involved methods. Contemporaneously with 
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ncDCT device development both the surface geometry and SD positioning 
concerns were addressed [20, 99]. 
To acquire the real sample geometry, a photogrammetric scanner (Figure 2.2; 
NextEngine, CA) proves a suitable solution. This 3D camera is oriented at an 
approximate working distance of 17 inches with a corresponding 10 inch × 13 inch 
field of view (FOV). Once stationed, the 3D surface mesh is acquired using the 
camera control software (ScanStudio HD, NextEngine, CA) and will include a 
reference plane and reference markings which have been manually placed by 
marker pen on the subject during ncDCT measurement. The markings generally 
correspond to the beginning, middle, and end step source positions for identifying 
the ncDCT lens apparatus translations (i.e., the SD arrangement and step length 
are static). A solid model is created by extruding a 2D contour (SolidWorks, 
Dassault Systemes, MA), where the shape chosen is based on sample similarity 
(i.e., circular for breast, rectangular for mouse), starting at the desired depth below 
and extending into the surface mesh. The finished solid volume must be of 
adequate size to allow diffusive photon propagation without creating a mesh of 
substantial processing burdens in reconstructions. From this solid, a 3D mesh was 
generated using ANSYS® (ANSYS, PA) with an appropriate average node 
distance (i.e., 1 or 2 mm based on previous experiments) and element shape (e.g., 
4-node tetrahedron). In this step, localized mesh refinement (or other advanced 
options) can be carried out. 
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Figure 2.2: Photogrammetric scanning camera. The 3D camera positioned over 
a mannequin exemplifying surface geometry recovery scanning. 
 
In noncontact-based applications the source and detection surface locations 
are not always as evident in comparison to contact designs. Mapping the projected 
source and detector positions is possible using the volume created by the 3D 
camera/extrusion and the source location reference markings. A program written 
to advantage the SolidWorks application programming interface (API) determines 
the positions in the following fashion. A plane is created perpendicular to the 
bottom plane (e.g., used for extrusion) whereby a line is created connecting the 
two source positions at an individual step. The program scans chief optical rays 
from the line to the sample surface with intersections denoting the proper SD 
coordinates. Errors of this method for alignment (< 10% error) were found to be 
negligible by simulated recovery of heterogeneity location (0.77 mm deviations < 
1 mm node distance) and flow contrast (1% deviation) [99]. 
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2.4 Flow Reconstruction 
 
The basis of the flow reconstruction procedure resides in the PDE (Equation 
1.1) and CDE (Equation 1.4) being analogous, which was the intent of the CDE 
[102]. The following Table 2.1 comparison of the equations (P1 approximations; 
PDE shown for CW source) and partial-flux boundary conditions (also called Robin 
boundary conditions; incoming photon/correlation flux only due to Fresnel 
reflections at the interface) illustrates their formal similarity [22, 102, 103]: 
 
Table 2.1: PDE, CDE, and boundary condition comparison 
P1 Approximation Diffusion Equations 
Photon Diffusion [∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎(𝒓)]Φ(𝒓) = −𝑣𝑆(𝒓) 
Correlation Diffusion [∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎
𝑡𝑜𝑡𝑎𝑙(𝒓, 𝜏)]G1(𝒓, 𝜏) = −𝑣𝑆(𝒓) 
 
Robin Boundary Conditions 
Photon Diffusion Φ(𝒎) + 𝑧𝑏(𝒎)
𝜕Φ(𝒎)
𝜕?̂?
= 0 
Correlation Diffusion G1(𝒎, 𝜏) + 𝑧𝑏(𝒎)
𝜕G1(𝒎, 𝜏)
𝜕?̂?
= 0 
 
where we have replaced the second and third terms in the CDE with a total 
absorption which includes dynamic processes as 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙(𝒓, 𝜏) = 𝜇𝑎(𝒓) +
1
3
𝛼𝜇𝑠
′(𝒓)𝑘0
2〈∆𝑟2(𝒓, 𝜏)〉 and that when assuming moving scatterers undergoing 
Brownian motion becomes 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙(𝒓, 𝜏) = 𝜇𝑎(𝒓) + 2𝜇𝑠
′(𝒓)𝑘0
2𝛼𝐷𝐵(𝒓)𝜏, ?̂? is normal to 
the surface, and the boundary conditions specify a boundary position 𝒎. Although 
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the notation exhibits spatial variation in both optical properties and 𝐵𝐹𝐼, the flow 
reconstruction method to follow attributes all changes to 𝛼𝐷𝐵(𝒓). 
As the analytic solutions for these equations are difficult to achieve except for 
simple cases, the problem is described by an FEM formulation which lends itself 
well to irregular boundaries and heterogeneous flow. The remaining details in this 
section are modified versions for flow (CDE) purposes from previous work done by 
others involving the FEM formulation, reconstruction implementations, and 
Jacobian calculation by adjoint method as originally outlined for photon fluence 
(PDE) and implemented in the NIRFAST (version 9.0) open source software 
package [104-107]. In FEM, we make the compromise of knowing the exact 
solution everywhere to that of an approximate numerical solution described in 
terms of a discrete set of elements and corresponding nodes. The FEM formulation 
derives a useful alternative problem formulation which provides the equivalent 
(approximate) solution to the CDE while allowing us to adjust the parameter 
surrogates. By continuously reducing the element size or increasing the nodal 
density, we expect ideally to effectively approach the exact solution for arbitrary 
media. 
The physical domain Ω is first partitioned into 𝐿 nonoverlapping volume (for our 
3D objective) elements 𝐸𝑖 joined at 4 vertex nodes 𝑁𝑖 (for 4-node tetrahedrons) 
with 𝐸𝑖: 𝑖 = 1…𝐿, 𝑁𝑖: 𝑖 = 1…4, and the entire region is then constructed from Ω =
∪𝑖=1
𝐿 𝐸𝑖. Also required is an estimate of the continuous physical distribution of the 
function of interest (e.g., 𝐺1). A piecewise linear polynomial shape function is thus 
defined with 𝜓𝑖(𝑁𝑗) = 𝛿𝑖𝑗 = {
1 𝑖 = 𝑗
0 𝑖 ≠ 𝑗
, 𝑖, 𝑗 = 1,… , 𝑃 where {𝜓𝑖}1
𝑝
 denotes a basis 
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function set with the total number of mesh nodes 𝑃 and has limited support (i.e., 
contributions only from elements sharing node 𝑁𝑖). The approximate solution 𝐺1
ℎ is 
then defined in terms of the basis as 𝐺1
ℎ(𝐫, 𝜏) = ∑ 𝐺1,𝑖(𝜏)𝜓𝑖(𝒓)
𝑃
𝑖=1 . There are no 
inherent mechanical relationships of significance between the nodes and 𝐺1 and 
thus no displacement occurs during analysis. This does not imply external factors 
haven’t inadvertently altered the true geometry such as subject movement or 
tissue compression during real measurements. 
The ability to establish the actual FEM solution is derived in detail for the 
analogous PDE elsewhere [64, 104, 105, 107-109]. Briefly, integrations are 
performed over each element and the total nodal contributions summed (based on 
limited support). The governing equations are given below where 𝜓𝑖 is related to 
𝐺1 being expressed in terms of the basis and 𝜓𝑗 is a trial function, resulting in a 
(sparse) 𝑃 × 𝑃 “mass” matrix and 𝑃 × 1 source and solution vectors: 
 
 [𝑲(𝐷) + 𝑪(𝜇𝑎
𝑡𝑜𝑡𝑎𝑙) + ζ𝑭]𝐆𝟏(τ) = 𝑺𝟎 (2.1) 
 
 𝐾𝑖𝑗 = ∫ 𝐷(𝒓)∇𝜓𝑖(𝒓) ∙ ∇𝜓𝑗(𝒓)Ω 𝑑Ω (2.2) 
 
 𝐶𝑖𝑗 = ∫ 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙(𝒓, 𝜏)𝜓𝑖(𝒓)𝜓𝑗(𝒓)Ω 𝑑Ω (2.3) 
 
 𝐹𝑖𝑗 = ∫ 𝜓𝑖(𝒓)𝜓𝑗(𝒓)𝑑(𝜕Ω)𝜕Ω  (2.4) 
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 𝑆𝑖 = ∫ 𝜓𝑖(𝒓)𝑆0(𝒓)𝑑ΩΩ  (2.5) 
 
where 𝜁 = 1/2𝐴 is arrived at by applying the Robin boundary condition to a 
boundary measurement defined by Γ(𝐦) = ?̂? ∙ 𝑱𝑮𝟏(𝒎) with normal surface vector 
?̂? and correlation flux 𝑱𝑮𝟏 at position 𝒎 [102, 104, 107], and 𝑮𝟏(𝜏) is the solution 
vector for nodal 𝐺1(𝜏). The integrations are evaluated by methods such as 
quadrature. The forward solution can be extracted manually or with the versatile 
MATLAB® (MathWorks, MA) slash operator for the typical 𝑨𝒙 = 𝒃 equation. Note 
that this entire arrangement is used to retrieve results in reference to a single 
source application/position. 
An inverse problem is required for taking our measured 𝐺1
𝑀 boundary data and 
finding the flow (technically the total absorption, 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙, is reconstructed) 
distribution which produced it. The approach in the modified NIRFAST follows a 
Tikhonov minimization with [105]: 
 
  χ2 = min
μa
𝑡𝑜𝑡𝑎𝑙
{∑ [𝐺1,𝑖
𝑀 (𝜏) − 𝐺1,𝑖
𝐶 (𝜏)]
2𝐵
𝑖=1 + 𝜆𝑇 ∑ [𝜇𝑎,𝑗
𝑡𝑜𝑡𝑎𝑙(𝜏) − 𝜇𝑎,0
𝑡𝑜𝑡𝑎𝑙(𝜏)]
2𝑃
𝑗=1 } (2.6) 
 
with 𝐵 boundary measurements (all valid SD pairs), 𝐺1
𝐶 is the forward solution, and 
a regularization parameter 𝜆𝑇 decreases the updated total absorption contribution 
each iteration. The resulting update is ultimately given, with the addition of a 
Jacobian sensitivity matrix 𝐽, by a Levenberg-Marquardt, 𝛿𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 = (𝐽𝑇𝐽 +
𝜆𝑇𝐼)
−1
𝐽𝑇𝛿𝐺1 with 𝜆𝑇 ≡ 2𝜆𝑇, or Moore-Penrose, 𝛿𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 = 𝐽𝑇(𝐽𝐽𝑇 + 𝜆𝑇𝐼)
−1𝛿G1, 
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procedure depending on the (secondary mesh) node and boundary measurement 
quantities. Further details of this implementation are given analogously for optical 
properties in the NIRFAST papers [105, 110]. Iterations are ended after ≤ 2% 
projection error between the measured and forward model boundary data. The 
reconstructed 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 is then finally used to extract the spatial distribution of 𝛼𝐷𝐵(𝒓). 
We retain the logarithmic transformation on 𝐺1 with the assumption that there is a 
large dynamic range of the data [104]. The Jacobian is formed with an adjoint 
method as summarized next. 
With the analogous (CW) diffusion equations and boundary conditions (Table 
2.1), the boundary measurement sensitivity is restated here in terms of 𝐺1 and total 
absorptions changes, within the FEM framework and utilizing the reciprocity 
relation, as [104, 106, 111] 
 
 
𝜕[Γ(𝜏)]𝒋
𝜕𝜇𝑎,𝑘
𝑡𝑜𝑡𝑎𝑙 = −𝚿𝐢
𝑻(𝜏)𝑽𝑘𝑮𝟏,𝒋(𝜏) = −𝑮𝟏,𝒋
𝑻 (𝜏)𝑽𝑘𝚿𝐢(𝜏) (2.7) 
 
where 𝑮𝟏,𝒋 corresponds to the CDE forward solution with 𝒓𝒋, 𝑉𝑘,𝑖𝑗(𝜇𝑎
𝑡𝑜𝑡𝑎𝑙) =
∫ 𝜓𝑘(𝒓𝒋)𝜓i(𝒓𝒋)𝜓j(𝒓𝒋)dΩΩ  is a basis system matrix arising from the expression of 
the total absorption in basis form 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙(𝒓𝒋, 𝜏) = ∑ 𝜇𝑎,𝑘
𝑡𝑜𝑡𝑎𝑙(𝜏)𝜓𝑘(𝒓𝒋)
𝑃
𝑘=1 , and 𝚿𝐢 is the 
solution to the CW adjoint problem [𝐊 + 𝐂 + ζ𝐅]𝚿i = 𝑺𝑖
+. In this latter problem 𝑆+ 
is a 𝛿-function source of type “Robin” (see Table 2.1 boundary conditions) at the 
measurement position 𝒎𝒊. The source has been tacitly assumed constant with 
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respect to changes in 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙. The sensitivity from Equation 2.7 can finally be 
applied to form the Jacobian matrix considering all valid SD pairs. 
Throughout the description of this flow reconstruction technique we have 
largely left the role of correlation time 𝜏 unaddressed. In practice, we select a single 
𝜏 leaving the reconstruction procedures nearly identical to the original PDE 
implementations. The choice for this parameter, the implications of 𝜇𝑎 and 𝜇𝑠
′  
contributions to the total absorption, and forward and inverse solution validations 
for ncDCT relative flow imaging has been examined in detail elsewhere [85, 112]. 
It may also be noted that 𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 is a function of 𝜏 as is an implicit exp (𝑖
2𝜋𝑐
𝜆
𝜏) on the 
CDE source term and should be taken into account in future analyses where the 
correlation time is not held constant in reconstructions [103]. 
 
2.5 Observations and Limitations 
 
There are several limitations with the ncDCT implementation. Although the 
lens apparatus may be scanned along the surface increasing lateral/rotational 
density, the linear SD array itself is static. This inhibits transitioning among subjects 
and ROI’s of varying sizes and restricts the ability to increase longitudinal SD 
density. The SD coverage is improved by mechanical scanning, but this movement 
is time consuming (up to 20 minutes). Artifacts due to subject and stager 
movements and potential physiological variations from the protracted duration may 
be introduced. Further difficulties occur in scaling the design to a greater number 
of SD pairs and patterns. Optical fibers and APDs incur inhibitive physical 
overhead with increasing number and the associated costs could have diminishing 
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returns. Such setups can also become exceedingly complex in accomplishing high 
spatial sampling density applications such as tomography. In the scDCT design 
we seek to remedy many of these shortcomings. Before moving on to this new 
design, a case study with ncDCT on a mouse tumor model is presented. 
 
2.6 Flow Imaging of Mouse Tumors with ncDCT 
 
In this investigation, we examine the flow contrasts between healthy and tumor 
tissue in a small animal model with ncDCT. Potential disadvantages of many 
current imaging techniques include costs and sensitivity only to morphological 
advancements. The microenvironment following rapid tumor growth is marked by 
enhanced angiogenesis and metabolic demand [1]. Functional physiological 
changes thus may serve as important biomarkers. The abnormal blood flow of 
such diseased tissue may provide detectable contrasts with surrounding normal 
healthy tissues. Small animal tumor models are employed in device development 
due to their availability, ease of control, tumor access, reduced complexity, and 
lower cost than human tumors. Imaging applied to small animals can provide a 
rapid segue between in-vitro assay-based and in-vivo clinical research and 
potentially produce results with fewer animals than traditional methods [28, 29]. 
Small animals can provide a faster and more cost-effective mechanism for 
evaluating criteria of potential concepts prior to a clinical trial. Combining the 
ncDCT technique with a mouse mammary tumor model allows visualization of 
tumor region blood flow contrasts with surrounding healthy tissues. 
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2.6.1 Tumor Model 
 
Human breast cancers commonly overexpress the ErbB-2 gene and breast 
cancer patients with high ErbB-2 have poor prognosis [113-115]. It has been found 
that ErbB-2 overexpression promotes hypersensitivity to ethanol [116]. 
Furthermore, ethanol has been found to encourage tumor growth and 
angiogenesis [117]. Due to its ethanol response, aggressive MDA-MB231 breast 
cancer cells may be investigated [117]. In the current case study, we employ 
ncDCT in measuring the blood flow characteristics of an athymic nude (NU/NU) 
mouse (Harlan Laboratories, IN) dorsally inoculated with aggressive MDA-MB231 
breast cancer cells (2 × 106 cells per each of two sites). The tumors were allowed 
to grow until palpable and one had reached at least 5 mm in diameter to promote 
high flow contrasts. Measurements were then acquired by ncDCT on two separate 
days denoted as Day 1 and Day 4. Mice were euthanized following the last 
measurement. All procedures were carried out according to the guidelines for the 
care and use of laboratory animals implemented by the National Institutes of 
Health and the Guidelines of the Animal Welfare Act approved by the Institutional 
Animal Care and Use Committee of the University of Kentucky. 
 
2.6.2 Data Collection 
 
Each measurement consisted of the following protocol. The mouse was first 
anesthetized through intraperitoneal injection. The animal was secured into 
position with its ventral side on a platform. The platform (excluding the mouse) was 
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covered to help minimize ambient light contributions. The ncDCT device as 
outlined in Chapter 2.2 is arranged longitudinally with the one laser source 
projected near the neck and the other the tail as shown in Figure 2.3.  Data is 
collected at 16 steps as the lens apparatus is mechanically scanned in 1.0 mm 
increments transverse to the head-tail orientation. At each step data was acquired 
at 0.5 Hz sampling with 15 s collection for each source, alternately. This data was 
fit using Equation 1.5 and the Siegert relation for a complete set of boundary 𝐵𝐹𝐼. 
The actual source positions were marked on the animal after the first and last step 
for SD coordinate calculations.  
 
 
Figure 2.3: ncDCT mouse tumor data acquisition. Illustration of the mouse 
orientation with respect to ROI, noncontact probe alignment, and scan direction. 
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Following ncDCT, photogrammetric scanning of the mouse curvature was 
taken, and a mesh was then created. The mesh was combined with the boundary 
data and calculated SD positions for flow reconstruction. The corresponding mesh 
of bounding dimensions (mm) [Day 1: 45.6 (H) × 21.4 (W) × 24 (D); Day 4: 46.7 
(H) × 18.4 (W) × 22.4 (D)] with nodes [Day 1: 25,610; Day 4: 20,885] of average 
1.00 mm node distance is shown in Figure 2.4 for both days with visualized SD 
locations. These complex boundary and mesh steps followed the methods 
described in Chapter 2.3. Of the total SD combinations, only pairs which coincide 
with each step of the linear apparatus positioning are valid resulting in 480 
boundary measurements (2 sources × 15 detectors × 16 steps). A secondary pixel 
basis mesh of [25 25 25], single delay time of 𝜏 = 3.2 × 10−6𝑠 [85], and optical 
properties of 𝜇𝑎 = 0.03 𝑚𝑚
−1, 𝜇𝑠
′ = 1 𝑚𝑚−1 were used in reconstructions. 
 
 
Figure 2.4: Coverage of source and detector locations on the mouse. The 
source (red spheres) and detector (yellow spheres) locations are shown for the (a) 
first day and (b) fourth day. 
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2.6.3 Results 
 
A region of known healthy tissue was used for normalization to produce tumor-
healthy relative blood flow [𝑟𝐵𝐹 = (𝛼𝐷𝐵/𝛼𝐷𝐵,0) × 100%; 𝛼𝐷𝐵,0 from healthy region] 
contrasts. From the tomographic reconstructions, a threshold of two standard 
deviations above the mean was used to separate the abnormal/tumor tissue flow 
from that of healthy tissues. Visual inspection supplemented the quantitative 
segmentation by manually categorizing regions as that of the large tumor, small 
tumor, or artifacts based on the known tumor palpations. In agreement with 
expectations, segmented regions were primarily limited to regions of tumor growth 
for both days as evidenced in Figure 2.5. There are two uniquely identifiable 
tumors on both occasions. 
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Figure 2.5: ncDCT mouse tumor reconstruction. The segmented 3-D tumor 
relative blood flow (rBF) contrasts for (a) day 1 and (b) day 4 are shown. 
Perspectives normal to the XZ and YZ plane are also shown (right). 
 
The tumor volumes (𝑉) and average relative tumor-healthy blood flows (𝑟𝐵𝐹) 
were quantified using the segmented and separated tumor data and listed in Table 
2.2. The tumor volumes both increased over the four days duration with an 
observed ~1.75- and ~3-fold change in the large and small tumors, respectively. 
The tumor blood flow averages exhibited a discrepancy between the large and 
small tumors. The smaller increased 25% while the larger decreased 10%.  
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Table 2.2: Recovered mouse tumor characteristics 
 Large Tumor Small Tumor 
 𝑽 (mm3) 𝒓𝑩𝑭 𝑽 (mm3) 𝒓𝑩𝑭 
Day 1 155.82 1.78 ± 0.78 11.82 1.20 ± 0.09 
Day 4 276.40 1.60 ± 0.70 34.84 1.50 ± 0.42 
 
2.6.4 Observations and Limitations 
 
The trend in tumor volumes from Table 2.2 for both tumors coincides with 
uncontrolled tumor growth. Further elevations in tumor volumes is anticipated to 
be minimal due to practical circumstances. Specifically, the tumors can begin to 
present with open wounds and the mouse subject will experience discomfort soon 
after the sizes observed. The varied average tumor blood flow is reasonable as 
the inside of solid tumors can develop poor circulation and even necrotic regions 
due to lack of nutrients and inadequate vessel structures. The resolution of ncDCT 
may not easily discern such regions until they grow to mm sizes but is still 
influenced by the partial volume effects on the boundary measurements. The 
average tumor flow contrast with healthy human breast tissues as measured by 
DCS and ncDCT in vivo have been reported between 2- to 10-fold [20, 58, 59]. 
The average flow contrast measured herein is just under this range. Some 
discrepancies due to partial volume effects, breast tumors in a mouse model, and 
lack of optical property information will contribute to inaccuracies in flow 
estimations [112, 118]. Overall, the application of the ncDCT technique to imaging 
small animal (mouse) mammary tumor blood flow contrasts was supported by this 
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case study. The regions of tumor tissues were identified and found localized 
proximal to their true locations. Average blood flow distributions were 
characterized with positive success in agreement with literature. 
There are areas where this study was limited and future optimizations which 
are both possible and necessary. The detection area being distributed across the 
entire animal is undesirable due to some asymmetry of internals (e.g., liver), large 
heterogeneity in tissue types and optical properties, large separation of SD 
combinations (i.e., SD sensitivity is typically half the separation distance), and laser 
source projections near the edges such as the neck and tail area. These 
deficiencies are predominantly due to the development of the ncDCT lens 
apparatus for human scale ROI’s. The mouse body is several centimeters in length 
and pushes the lens focusing apparatus to the margins of its applicability. Future 
studies should narrow the ROI to a smaller region of tissue and SD separations 
which limit penetration and optimize sensitivity. In proceeding chapters, instrument 
design allows for this robust translational potential. 
Measurement of the tissue optical properties can be accomplished through 
addition of DOS/DOT techniques to attempt further improvements in blood flow 
estimates. The absorption and reduced scattering coefficients used coincided with 
literature, but there is a large variation across tissue types [119-122]. 
The scan time, also addressed in proceeding chapters, is another undesirable 
system trait. The animal though secured and anesthetized has intermittent 
exaggerated respirations and twitches which can introduce artifacts over the scan 
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period of ~8 minutes. Reducing the data collection duration will help reduce the 
impact of these occurrences. 
The modest boundary curvature makes suspect that there is consistent 
modeling with the semi-infinite solution (Equation 1.5). Monte Carlo (MC) 
modeling may improve the recovered data and understanding of the curvature and 
angle of incidence influences. A previous study noted curvature influence on 
absolute 𝛼𝐷𝐵 with a negligible affect on 𝑟𝐵𝐹 [98]. Such analysis uses the form of 
𝑔1 explicitly including the path length distribution as obtainable from MC 
simulations. In future mouse studies an assumption of negligibility should be 
assumed invalid and require case-specific analysis. This is due to the spatial 
heterogeneity of curvature which will also change over time with a palpable tumor. 
The progression of size in the smaller tumor as seen in Figure 2.5 is thus expected 
to supply less reliable results. Additionally, the separation for a particular SD pair 
as defined for the semi-infinite solution uses a flat boundary, but has ambiguous 
meaning (e.g., shortest direct distance or geodesic distance) and inaccurate 
applicability with regard to a curved boundary. Alternatively, limiting the ROI to a 
smaller area can reduce these effects with a sufficiently modified lens apparatus 
as mentioned above. A technique developed specifically for extracting DCS flow 
indices on complex curvatures has recently been developed and may be 
incorporated in future studies for flow boundary data reconciliation [123, 124].  
Several other improvements may also be incorporated into future related 
studies. Further flow progression information can be made available by extending 
the longitudinal monitoring to earlier time points including early tumor growth. To 
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support the findings shown, validation should be performed against other 
modalities and/or techniques such as CD34/microvessel density after tumor 
excision. Lastly, a heating element is needed to assist in maintaining the animal 
body temperature and preventing flow changes throughout the measurement 
duration. 
An uncertainty arose after the measurements were concluded concerning the 
source fiber attachments to the lens focusing apparatus. The source orientation 
(i.e., source 1 top/source 2 bottom or source 1 bottom/source 2 top) was 
determined by comparing usage of the ncDCT device in experiments near the 
relevant dates and the results for the 2 separate mouse measurement days. 
Several other mice were measured, but due to insufficient data for longitudinal/self-
comparison and compounding complications in assumptions from the uncertainty 
above they were excluded from analysis. 
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CHAPTER 3 SPECKLE CONTRAST DIFFUSE CORRELATION 
TOMOGRAPHY 
 
3.1 Introduction 
 
In this chapter we proceed from APD’s to CCD detection and develop the 
background for moving between speckle contrast flow measurements and our flow 
reconstruction technique while describing the system built for exemplification. As 
this method transitions raw flow measurements from intensity correlation to 
speckle contrast we term it speckle contrast DCT (scDCT). This unique system 
facilitates CCD-based 3D flow contrast imaging of complex turbid media. We first 
look at the scDCT instrumentation and how it is oriented for taking data in an 
experimental setup. Following this is the derivation of the speckle contrast flow 
detection in semi-infinite media which enables utilizing the CCD camera as 
opposed to APD’s. We continue with the image pre-processing details including 
noise corrections and a smear correction algorithm. Finally, we apply this scDCT 
technique on reflectance-based measurements of tissue-like phantoms. The 
derivation [100] and system and experimentation [125] described herein have been 
published. A low cost compact spectroscopic alternative has also been proposed 
[126]. 
 
3.2 Instrumentation and Experimental Setup 
 
In scDCT we replace the APD detection elements of ncDCT by a single highly 
sensitive electron-multiplying CCD (EMCCD; Cascade 1K, Photometrics, AZ). This 
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method of detection allows for many (e.g., up to ~1 million [1004 x 1002 pixels]; 
camera dependent) effective detector measurements due to the populated pixel 
grid. It also removes the scanning overhead and time penalty of the ncDCT design. 
The camera specifications are shown in Table 3.1. The maximum full frame rate 
achievable is ~9 frames per second (fps; we average ~8 fps in practice) without 
binning (up to ~33 fps with binning at the expense of resolution; no binning is used 
in the current investigation). The quantum efficiency of the camera is shown in 
Figure 3.1. The 785 nm long-coherence laser (coherence length > 5 m; 
CrystaLaser, NV) used coincides with a quantum efficiency slightly under 45% 
from the referenced figure. The camera backing is mounted to a heavy base 
seated upon a mobile cart which can be quickly moved between laboratory settings 
and clinical rooms. The reflectance mode orientation more adequately represents 
the situation encountered in larger subjects such as humans where transmission 
is not practical in most cases (due to the limited penetration depth of light), 
enhancing translatability to different ROI’s and subjects (e.g., small animals). 
 
Table 3.1: Cascade 1K EMCCD specifications 
Specification Details 
Format 1004 pixels x 1002 pixels; 8 µm x 8 µm pixels 
Linear full well single pixel 30,000e- 
Digitizer 16 bits @ 10 MHz 
Frame readout 110 ms/frame; 1 ms (image-to-storage shift time) 
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Figure 3.1: Quantum efficiency of the Cascade 1K EMCCD. The quantum 
efficiency corresponding to the 785 nm laser source is denoted by a dashed red 
line.  
 
A zoom lens (Zoom 7000, Navitar, NY) is attached to the CCD camera opening 
as shown in Figure 3.2a. The lens is aligned concentrically to the FOV over a liquid 
phantom surface (Figure 3.2b). The zoom lens was set with a 35 mm focal length 
and F-number of 8 to make the focal plane agree with a tissue-like liquid phantom 
surface and to satisfy the speckle size Nyquist sampling criteria [127], respectively. 
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Figure 3.2: CCD camera and experimental setup. (a) The EMCCD is focused 
by zoom lens onto a liquid phantom surface. A square metal holder positioned the 
ferrule tips of four optical fibers on the liquid surface. The holder provided a 2.4 cm 
× 2.4 cm open area. The optical switch distributed laser light into the four source 
fibers sequentially. (b) Configuration of the four sources, CCD, FOV, solid phantom 
placement, and detector area. 
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A blocking fiber optic switch (VX500, DiCon, CA) was custom designed with 
two-channel inputs and four-channel outputs. Here we use it to deliver photons 
from a single laser input to four multimode optical fibers (FT200UMT, Thorlabs, 
NJ; 200 µm core fiber with 0.39 NA and FC/PC connector) individually (see 
Figures 3.2a and 3.3). The 2 × 4 switching mechanism is reversible and can allow 
low-loss light throughput in the opposite direction in future applications. The switch 
is optimized for wavelengths in the range of 600 – 860 nm. The switch output fibers 
(S1 to S4 in Figure 3.2b) were led to a metal holder with a 2.4 cm × 2.4 cm open 
center with their ferrule tips held in place symmetrically around the FOV perimeter. 
The effective positions were located 1.5 cm from the FOV edge centers. A 
LabVIEW® (National Instruments, TX) program was written to control the optical 
switch operation through an A/D board. 
 
 
Figure 3.3: The blocking and switching mechanism of the optical switch. The 
785 nm laser light was connected to input 1 and sequenced from output 1 through 
4. The blocking feature restricts input 2 light from passing through any output 
channel when only input 1 light passage is desired (or conversely). No light source 
is connected to input 2 in the current investigation. 
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3.3 Speckle Contrast 
 
To facilitate determination of blood flow indices by CCD detection we borrow a 
concept from LSCI termed speckle contrast. In typical LSCI a wide-field light 
source is applied across a region for monitoring superficial flow variations by 
quantifying the speckle contrast in a local region as [87]: 
 
 𝐾𝑠(𝒓) =
𝜎𝑠
〈𝐼〉
 (3.1) 
 
where 𝜎𝑠 is the spatial (or temporal) standard deviation and 〈𝐼〉 is the mean intensity 
of a set of pixels (e.g., a window). We seek to extend this into speckle patterns 
created by photons having traversed diffusely up to a few centimeters depth within 
biological tissues. We thus turn to the following relationship (assumes the Siegert 
relation) between the speckle contrast parameter and 𝑔1: 
 
 𝐾𝑠
2(𝒓) =
2𝛽
𝑇
∫ (1 −
𝜏
𝑇
)𝑔1
2(𝒓, 𝜏)
𝑇
0
𝑑𝜏 (3.2) 
 
where 𝑇 is the exposure time and 𝛽 relates the detector and speckle sizes [128]. 
Using the normalized semi-infinite analytic solution 𝑔1(𝒓, 𝜏) = 𝐺1(𝒓, 𝜏)/𝐺1(𝒓, 0)  
from Equation 1.5 and rewriting we obtain 
 
 𝑔1(𝒓, 𝜏) = 𝐶[𝑟2 exp(−𝑟1𝑀) − 𝑟1 exp(−𝑟2𝑀)] (3.3) 
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where 𝐶 = [𝑟2 exp(−𝑟1√3𝜇𝑎𝜇𝑠′) − 𝑟1 exp(−𝑟2√3𝜇𝑎𝜇𝑠′)]
−1
. Inserting Equation 3.3 
into Equation 3.2, 
 
 𝐾𝑠
2(𝒓) =
2𝛽𝐶2
𝑇
[
 
 
 
 
 
 
∫ {
𝑟1
2 exp(−2𝑟2𝑀)
−2𝑟1𝑟2 exp(−[𝑟1 + 𝑟2]𝑀)
+𝑟2
2 exp(−2𝑟1𝑀)
}𝑑𝜏
𝑇
0
−
1
𝑇
∫ 𝜏 {
𝑟1
2 exp(−2𝑟2𝑀)
−2𝑟1𝑟2 exp(−[𝑟1 + 𝑟2]𝑀)
+𝑟2
2 exp(−2𝑟1𝑀)
}𝑑𝜏
𝑇
0
]
 
 
 
 
 
 
 (3.4) 
 
which can be rewritten in terms of 𝑀 as 
 
 𝜏 =
𝑀2−3𝜇𝑎𝜇𝑠
′
6𝜇𝑠
′2𝑘0
2𝛼𝐷𝐵
 (3.5) 
 
and 
 
 𝑑𝜏 =
𝑀
3𝜇𝑠
′2𝑘0
2𝛼𝐷𝐵
𝑑𝑀. (3.6) 
 
We can consider the integrals of the following two general forms with their 
corresponding solutions 
 
 𝐴 =
1
3𝜇𝑠
′2𝑘0
2𝛼𝐷𝐵
∑ 𝑥𝑖 ∫ 𝑀 exp(𝑦𝑖𝑀)𝑑𝑀
𝑏
𝑎
3
𝑖=1   
 
 =
1
3𝜇𝑠
′2𝑘0
2𝛼𝐷𝐵
∑ (
𝑥𝑖
𝑦𝑖
2) [(𝑦𝑖𝑏 − 1) exp(𝑦𝑖𝑏) − (𝑦𝑖𝑎 − 1) exp(𝑦𝑖𝑎)]
3
𝑖=1  (3.7) 
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and 
 
𝐵 =
1
18𝜇𝑠′
4𝑘0
4(𝛼𝐷𝐵)2
∑𝑥𝑖 ∫(𝑀
2 − 3𝜇𝑎𝜇𝑠
′)𝑀 exp(𝑦𝑖𝑀)𝑑𝑀
𝑏
𝑎
3
𝑖=1
 
 
 =
1
18𝜇𝑠
′4𝑘0
4(𝛼𝐷𝐵)2
∑ (
𝑥𝑖
𝑦𝑖
4) [
(
𝑦𝑖
3𝑏3 − 3𝑦𝑖
2𝑏2 − 𝑦𝑖
3𝑏𝑎2
+6𝑦𝑖𝑏 + 𝑦𝑖
2𝑎2 − 6
) exp(𝑦𝑖𝑏)
+2(𝑦𝑖
2𝑎2 − 3𝑦𝑖𝑎 + 3) exp(𝑦𝑖𝑎)
]3𝑖=1  (3.8) 
 
with 𝑥𝑖 = {
𝑟1
2 𝑖 = 1
−2𝑟1𝑟2 𝑖 = 2
𝑟2
2 𝑖 = 3
 , 𝑦𝑖 = {
−2𝑟2 𝑖 = 1
−(𝑟1 + 𝑟2) 𝑖 = 2
−2𝑟1 𝑖 = 3
, 𝑎 = √3𝜇𝑎𝜇𝑠′  and 𝑏 =
√6𝜇𝑠′
2𝑘0
2𝛼𝐷𝐵𝑇 + 3𝜇𝑎𝜇𝑠′ . The final solution is then 
 
 𝐾𝑠
2(𝒓) =
2𝛽𝐶2
𝑇
[𝐴 −
1
𝑇
𝐵] (3.9) 
 
The theoretical diffuse speckle contrast can be seen to be a function of several 
parameters, explicitly 𝐾𝑠
2(𝒓) = 𝑓(𝛼𝐷𝐵, 𝑇, 𝜇𝑎, 𝜇𝑠
′ , 𝜆, 𝛽, 𝑘0, 𝒓). We assume that all 
parameters remain constant throughout the camera integration time. All 
parameters are known, measurable, or estimated from literature except for 𝛼𝐷𝐵 
(i.e., the blood flow index, 𝐵𝐹𝐼). The relationship between the diffuse speckle 
contrast, SD separation, and exposure time 𝑇 is nonlinear as shown in Figure 3.4. 
 
45 
 
 
Figure 3.4: Variation in diffuse speckle contrast. Variations in speckle contrast 
are shown over a typical range of SD separations and exposure times 𝑇. 
 
Extraction of the 𝐵𝐹𝐼 for each SD pair is carried out as follows. The 
experimentally measured diffuse speckle contrast is calculated from CCD camera 
measurements by Equation 3.1 with noise corrections, which we term 𝐾𝑠𝑒 for 
illustrative purposes. The theoretical diffuse speckle contrast is calculated by 
Equation 3.9, similarly termed 𝐾𝑠𝑡
2 . As 𝐵𝐹𝐼 is unknown, we finally minimize the 
squared difference between the two speckle contrasts, min
𝛼𝐷𝐵
(𝐾𝑠𝑒
2 − 𝐾𝑠𝑡
2 )2, with 
respect to 𝐵𝐹𝐼. 
The 𝐵𝐹𝐼 obtained from this speckle contrast method by CCD detection is 
considered equivalent to that obtained from APDs and Equation 1.5. As such, 
reconstructing flow distributions is performed as described in Chapter 2 with the 
difference only existing in the acquisition of the boundary 𝐵𝐹𝐼 data.  
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3.4 Image Pre-Processing and Reconstruction 
 
Prior to applying speckle contrast-based flow recovery, the raw images were 
preprocessed to account for several negative factors including smear and noise 
contributions. The speckle contrast obtained from a frame transfer EMCCD 
camera may deviate from the theoretical value due to intensity disorder originating 
from the frame transfer process [129]. More specifically, visual stripes (smears) 
are induced extending from bright features in the image into the direction opposite 
that of the charge transfer process. Along this direction, the smear can be 
corrected using an algorithm described by Equation 3.10. The actual pixel 
intensity signal of the 𝑥th column and 𝑦th row, 𝑖(𝑥, 𝑦), can be restored by the 
measured value 𝑖′(𝑥, 𝑦) with 
 
 𝑖(𝑥, 𝑦) = 𝑖′(𝑥, 𝑦) −
𝜂𝑓𝑡𝑡𝑓𝑡
𝑛𝑝𝑇
∑ 𝑖(𝑥, 𝑛)𝑦−1𝑛=1  (3.10) 
 
where 𝑡𝑓𝑡 is frame transfer time, 𝑛𝑝 is number of pixel rows when the frame has 
moved to the readout buffer, and 𝜂𝑓𝑡 is the efficiency with which photoelectrons 
are generated during the charge-transfer process relative to the efficiency with 
which photoelectrons are generated during the image capture period. Our EMCCD 
frame transfer time is ~1 ms. We set 7 × 7 windows at the same distance to the 
source location for a symmetric intensity distribution, leading to 𝜂𝑓𝑡 value of 0.67. 
Speckle contrast contributions due to hardware noise (i.e., shot noise and dark 
noise) are accounted for correcting the speckle contrast computation (Equation 
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3.1) of windowed regions [94, 130]. Details of these corrections can be found 
elsewhere [94]. Briefly, dark images are used to mitigate speckle contrast 
influences from dark noise, 𝐼𝑐 = 𝐼 − 𝐼𝐷, where 𝐼 is the original intensity of a single 
pixel and 𝐼𝐷 is the intensity of dark current. The shot noise of 𝐼𝐶 follows Poisson 
statistics, 𝜎𝑠(𝐼𝐶) = √𝜇(𝐼𝐶), which are incorporated into the correction calculation. 
The shot and dark corrected speckle contrast is then given by 
 
 𝐾 = √
𝜎2(𝐼)−𝜎2(𝐼𝐷)−𝜎𝑆
2(𝐼𝐶)
𝜇2(𝐼𝐶)
. (3.11) 
 
The tomographic reconstruction process is the same as described in Chapter 
2 with the boundary 𝐵𝐹𝐼 now provided as described in Chapter 3.3 and above. A 
single delay time of 𝜏 = 3.2 × 10−6 𝑠 was used [85]. The SD separation is 
determined for each effective detector as the center of the region covered by its 
associated pixels.  
 
3.5 Experimental Protocol 
 
Two types of tissue-like phantoms were incorporated for experimentation. The 
background consisted of a liquid phantom mixture comprised of distilled water, 
India ink (Black India 44201, Higgins, MA), and Intralipid (Fresenius Kabi, 
Sweden). This phantom maintained an effectively homogeneous set of optical 
properties comparable to real tissues as 𝜇𝑎 = 0.05 𝑐𝑚
−1 and 𝜇𝑠
′ = 7.0 𝑐𝑚−1 and 
flow from Intralipid particle Brownian motion as 𝐷𝐵 ≅ 1 × 10
−8 𝑐𝑚2/𝑠 (assumed 
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[118]). In our homogeneous liquid phantom experimentation all scatterers are 
dynamic (𝛼 = 1) and we thus write 𝐷𝐵. For satisfying the need for flow contrast, a 
7 mm side length cube-shaped solid phantom was created of carbon black (Alfa 
Aesar, IL), titanium dioxide (Alfa Aesar, IL), and silicone (Circuit Specialists Inc, 
AZ) [112]. Its associated properties supplied 𝐷𝐵 about three orders of magnitude 
lower than the liquid phantom background while matching optical properties (𝜇𝑎 =
0.05 𝑐𝑚−1, 𝜇𝑠
′ = 7.0 𝑐𝑚−1). The cube was submerged at 2 mm depth beneath the 
surface in the FOV center. 
The scDCT speckle contrast measurement protocol was identical for both the 
presence and absence of the solid cube in the liquid phantom background and was 
as follows. A source position was first selected with the optical switch. The CCD 
camera then acquired 30 frames at a frame rate of 8 fps while set at 2 ms exposure 
time. Collection of raw images was repeated in this manner for the remaining three 
source positions. A set of 9 × 9 detectors were defined and centered in the FOV 
over 1.0 cm × 1.0 cm (Figure 3.2b) surrounding the cubical target (when 
applicable). With the static source and defined detector positions, SD separations 
ranged from 1.0 to 2.0 cm with 1.25 mm detector separation distance. Each 
detector (0.42 mm × 0.42 mm) was comprised of 3 × 3 windows which in turn 
contained 7 × 7 pixels (8 μm pixel size). For each preprocessed image, the speckle 
contrast was calculated per window and subsequently averaged across all 
windows corresponding to their associated detector. Localized speckle contrast 
averages were then calculated along obtained frames for all sources. 
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Prior to heterogeneity inclusion, the homogeneous phantom was measured 
with scDCT and DCS for calibration purposes. Practically, the optical constant 𝛽 
for CCD is not available for measurement. Therefore, a DCS instrumentation was 
utilized with an APD-connected single-mode detection fiber (𝛽 = 0.5) to measure 
𝐵𝐹𝐼 as calculated by Equation 1.5 and thus serving as the standard. This 𝐵𝐹𝐼 was 
used with Equation 3.9 providing the expected speckle contrast with unknown 𝛽 
(for CCD). As the sample was homogeneous with respect to the optical properties 
and 𝐵𝐹𝐼 this enabled the determination of appropriate calibration factors at all SD 
separations. 
 
3.6 Smear Correction Improvements and Speckle Contrast Flow Validation 
 
The influences of smear correction are considered first. Figure 3.5a illustrates 
the intensity distribution with source S2 on the homogeneous phantom. The bias 
of intensity is evident in the direction of frame transfer (towards S2). Figure 3.5b 
shows the distribution after desmearing, demonstrating a normal presentation for 
point source intensity. To quantify the desmearing influence we consider an array 
of detectors defined along the center row in line with the source location as shown 
relative to S2 in Figure 3.5a. The number of effective detectors is increased to 21 
along this line (see the ROI and dots in Figure 3.5a) for enhanced illustration of 
the smear influence. The detectors are otherwise defined as outlined previously. 
The SD ranges from 1.0 to 2.0 cm. Each remaining source is processed to examine 
smear correction influence similarly, but with different center row orientation based 
on source location. The measured 𝐾 for such detectors and each source with and 
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without desmearing is shown in Figure 3.6a, along with the calculated 𝐾. It can be 
seen that the desmeared 𝐾 correlates with the calculation. The region of usable 
speckle contrast without desmearing is obviously limited with S2 most noticeably 
impacted. This is due to our system configuration in which frame transfer occurs 
in the direction from S4 to S2.  
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Figure 3.5: Effect of smear correction on image intensity. (a) Original intensity 
pattern for source S2 on the homogeneous phantom. (b) Desmeared intensity 
distribution of (a) with a corresponding SD separation axis. These images depict 
contours of the intensity profiles with dots representing 21 effective detectors for 
demonstrating the 𝐾 distribution with the SD separations. Note that the dots are 
not to scale and the smaller dots serve as an ellipsis for the intermediate detectors. 
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Figure 3.6: Speckle contrast 𝐾 and 𝐷𝐵 influences from smear. (a) 𝐾 for all 
sources from detectors defined along the center row with and without smear 
correction (SC) and numerically simulated 𝐾 at the SD separations. (b) 𝐷𝐵 for 
center row detectors. 
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After smear correction we can compare the flow indices measured by the new 
EMCCD speckle contrast method and standard DCS. Continuing from the previous 
analysis, the 𝐷𝐵 value across the center row of detectors is shown in Figure 3.6b. 
The 𝐷𝐵 values achieved from DCS at 2.0 cm SD separation and those 
independently averaged for S1 to S4 at the 21 detectors are shown in Table 3.2. 
The CCD measured 𝐷𝐵 are in good agreement (within 12%) with the standard DCS 
measurement. The comparison of 𝐾 distributions measured from S1 on the 
homogeneous and heterogeneous phantoms is shown in Figure 3.7. 
 
Table 3.2: Average DB from EMCCD and DCS 
Source Average 𝑫𝑩 (× 𝟏𝟎
−𝟖 𝒄𝒎𝟐/𝒔) 
EMCCD – S1 1.19 ± 0.05 
EMCCD – S2 1.18 ± 0.08 
EMCCD – S3 1.17 ± 0.06 
EMCCD – S4 1.13 ± 0.06 
DCS @ 2.0 cm SD 1.28 
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Figure 3.7: Measured speckle contrast distributions on homogeneous and 
heterogeneous phantoms. 
 
3.7 Flow Heterogeneity Detection and Characterization 
 
To examine the performance of scDCT in detecting and characterizing flow 
contrast, we next measure the liquid phantom with the submerged solid cube 
heterogeneity (Figure 3.2b). Boundary 𝐵𝐹𝐼’s were acquired from measured 
speckle contrast, using Equations 3.1 and 3.9, and combined with those obtained 
from the homogeneous phantom for relative changes. The boundary flow 
information and valid SD pairs were integrated with the following mesh for image 
reconstructions. A finite element mesh [dimension (mm): 60 (H) × 60 (W) × 30 (D)] 
centered at (0, 0, 15) with an average 3 mm node distance, 4-node tetrahedrons, 
and optical properties matching the phantoms provided a slab-shaped 
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representative geometry. The mesh was refined in the region known to contain the 
heterogeneity to improve detection resolution while not overwhelmingly increasing 
the number of nodes. Refinement was within a 15 mm radius (e.g., inclusive of 5 
elements) centered from (0, 0, 30) to a 1.5 mm node distance (total nodes: 10,307) 
using ANSYS. The relative blood flow, 𝑟𝐵𝐹, is used to denote the ratio of phantom 
with heterogeneity to homogeneous phantom 𝛼𝐷𝐵’s. The reconstructed image 
from homogeneous phantom and heterogeneous phantom are shown in Figures 
3.8a – 3.8b. A reconstructed heterogeneity was clearly recognizable from the 
overlaid cross-sections compared between the two images. Figure 3.8c shows 
cross-sectional views of the heterogeneity extracted by half max contrast threshold 
criteria. The averaged heterogeneity 𝑟𝐵𝐹 was 0.38 with center (-0.0, -0.1, 25.0) 
close to the actual center (0, 0, 24.5). Reconstructed heterogeneity side length 
was 7.2 mm with dimensions that were accurate compared to the true solid 
phantom. 
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Figure 3.8: Reconstructed 3D flow contrasts. Two-dimensional cross-sectional 
view (x and y through side centers; z at 24.5) of slab phantom (a) without 
heterogeneity and (b) with heterogeneity. (c) The region with heterogeneity as 
extracted by half max contrast threshold criteria. The true region with heterogeneity 
is depicted by centered squares. (d) The extracted (half max contrast threshold) 
region with heterogeneity obtained by computer simulation. 
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For comparison with the ideal scenario, we simulated the phantom experiment 
by computer using identical parameters. The region with heterogeneity extracted 
by half max contrast threshold is shown in Figure 3.8d. The reconstructed 
heterogeneity averaged 𝑟𝐵𝐹 was 0.37 with center (-0.1, 0.0, 24.0), similar to 
phantom results (averaged 𝑟𝐵𝐹 within 3% of phantom test results). Corresponding 
3D flow distributions were also similar to the phantom experiment (Figure 3.8b) 
and hence not shown. In order to examine the effect of centering the heterogeneity 
symmetrically in the FOV, we also performed two simulations with it placed in off-
center locations, but in an otherwise matching setup. The reconstructed center and 
side length were both in agreement with expectations.  
 
3.8 Observations and Limitations 
 
In this study, an exposure time of 2 ms was selected to achieve a good contrast 
to noise ratio [131]. Inherent in this selection was an adverse smear effect. This 
was resolved by post data collection analysis, but other solutions exist such as 
shutters or laser gating. The reconstruction and boundary data parameters of delay 
time 𝜏 and window size used herein have been discussed elsewhere [88, 132]. We 
acknowledge that static scatterer contributions can degrade the current model. 
Ideally, recovered 𝑟𝐵𝐹 would be zero. However, we only sought to validate 3D flow 
contrast detection using our new scDCT method rather than optimize flow recovery 
accuracy, and we produced sufficient contrast to identify and characterize the 
anomalous presence. The agreement between scDCT and DCS on a 
homogeneous phantom and between simulation and phantom in heterogeneity 
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detection supports success. Furthermore, multiple two-dimensional SD pairs 
provided by the CCD omits the probe scanning in ncDCT, and thus significantly 
improves the spatial and temporal resolution.  In addition, due to decreasing signal 
with increased SD separation using a point source we were limited to at most 2.2 
cm after noise correction. Nevertheless, this SD separation is still capable of 
probing tissues ~1 cm depth.  
We also note that although the FEM framework allows incorporating complex 
heterogeneities and boundaries we chose to exemplify our technique in a 
straightforward setup. Further difficulties may be encountered when extending 
scDCT to real complex media. For example, surface curvature may result in 
modified light distributions and SD separations potentially reducing the accuracy 
and reliability of reconstructed flow contrasts as was described in Chapter 2.6. 
These issues can be addressed in the future through computer simulations, 
possible free-space corrections [80], and telecentric zoom lens incorporation [133, 
134]. To improve results we additionally refined the mesh in the center region 
around the known cubical heterogeneity location. 
Compared to our previous ncDCT design, this system demonstrated potential 
for fast and dense boundary data acquisition and deep tissue hemodynamics 
tomography translating directly to human studies (e.g., burn/ulcerous tissue flow 
detection). However, as the scDCT was designed primarily to further the CCD-
based detection and novel speckle contrast flow detection some features are 
limited. The contact-based source fibers are undesirable in practice due to 
compression-induced hemodynamic and optical property changes [77, 78], 
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potential situations of wound sensitivity and exposure, being restricted to outside 
the camera FOV, and the difficulties in greatly increasing their quantity. This 
system is also not capable of imaging fluorescence distributions. A fully noncontact 
scDCT (nc_scDCT) has been developed and combined with DFT capabilities in 
the next chapter concerning the final instrumentation which performs both flow and 
fluorescence imaging. 
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CHAPTER 4 NONCONTACT SPECKLE CONTRAST DIFFUSE 
CORRELATION AND DIFFUSE FLUORESCENCE TOMOGRAPHY 
 
4.1 Introduction 
 
In this chapter advancements have been made to purpose a prototype diffuse 
optical instrument in which all the beneficial operational characteristics including 
noninvasiveness, reflectance mode, noncontact, translational, and sensitivity to 
both flow and fluorescence changes are borne conjointly. The extension builds 
upon the designs and techniques of ncDCT and scDCT and its noncontact version 
(nc_scDCT) as described first. The role of ICG as our fluorescent agent of choice 
and the related implications is supplied. The chapter is rounded out by the custom 
designed experimental setup and protocol for executing a combined flow and 
fluorescence contrast validation. A separate publication illustrated the independent 
nc_scDCT instrumentation and its testing in vivo [100]. 
 
4.2 Multimodal Noncontact Speckle Contrast Diffuse Correlation and 
Diffuse Fluorescence Tomography Prototype 
 
A scanning galvo-mirror (GVS002, Thorlabs, NJ) was added for directing laser 
source light around the FOV in noncontact fashion (Figure 4.1). As this and the 
following supporting elements remove the static optical fiber source positioning 
present with scDCT, the method is termed noncontact scDCT (nc_scDCT) [100]. 
To situate the galvo-mirror at a versatile vantage point, a metal support abreast of 
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the CCD camera and out of the FOV was machined and installed. Detection of 
potential source light reflections from the sample surface which have not travelled 
through the tissue are minimized by installation of cross polarizers. The first 
polarizer (LPNIRE050-B, Thorlabs, NJ) is interposed between a lens doublet at the 
source fiber connector and the galvo-mirror. The second polarizer (LPNIRE200-B, 
Thorlabs, NJ) is placed in a stackable tube (SM2L05, Thorlabs, NJ) in the path of 
detected light at the zoom lens entrance. 
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Figure 4.1: Combined nc_scDCT and DFT instrumentation. A laser source fiber 
directs light into a lens and polarizer before being redirected to the sample surface 
by the galvo-mirror. Light having travelled through the tissue and reflected from the 
surface passes through two stackable tubes before interacting with the zoom lens 
and CCD. The initial tube contains either a 775nm bandpass filter (775BP) or 
800nm longpass filter (800LP). The proceeding tube contains a polarizer in cross 
orientation with the source polarizer to remove reflected light. 
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In order to isolate the different signals of interest one of two stackable tubes is 
placed in front of the polarizer at the zoom lens at any given time. For acquiring 
𝐵𝐹𝐼(785𝑛𝑚) or 𝜇𝑎(785𝑛𝑚) a 775 nm bandpass filter (775BP; 86-968, 
EdmundOptics, NJ) is placed in one stackable tube. For acquiring 𝐵𝐹𝐼(830𝑛𝑚), 
𝜇𝑎(830𝑛𝑚), or 𝜂𝜇𝑎,𝑓𝑙 an 800 nm longpass filter (800LP; 84-762, EdmundOptics, 
NJ) is placed in another stackable tube. These stackable tubes are manually 
exchanged as necessary during experimentation along with the appropriate laser 
source. The polarizers remain in place throughout operation. 
 
4.3 Indocyanine Green and Source Light 
 
Indocyanine green (ICG) is a frequently used and documented fluorescent dye 
in the NIR spectrum [16, 17, 19, 30, 33, 35, 135]. It is also FDA approved and 
relatively inexpensive. The excitation and emission spectrum of ICG in whole blood 
are shown in Figure 4.2. In our liquid phantoms we incorporate water, Intralipid 
(primarily water), and ink (primarily water) which comprising a primarily aqueous 
solution can diminish the fluorescent properties after ~6 hours. The experimental 
protocol in this study therefore confines the total experiment duration (once ICG is 
prepared in aqueous solutions) to within this interval. Furthermore, our preliminary 
testing in similar phantom arrangements to those used herein suggested that the 
785 nm laser (as used with scDCT; Chapter 3) produced adverse flow results at 
high ICG concentrations. An 830 nm laser (as used with ncDCT; Chapter 2) was 
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therefore also incorporated for comparison due to its increased distance from the 
ICG absorption peak (Figure 4.2). 
 
 
Figure 4.2: ICG and laser sources. The normalized excitation and emission 
curves of ICG are shown with the wavelengths of the two laser sources (785 and 
830 nm) used. It is expected that the 830 nm laser 𝐵𝐹𝐼 recovery will exhibit a 
diminished influence from the presence of ICG due to its location lower in the 
absorption/excitation spectrum. 
 
4.4 Experimental Setup 
 
The noncontact source/detection apparatus is located directly above a 
container filled with liquid phantom background, 𝜇𝑎(785𝑛𝑚) = 0.05 𝑐𝑚
−1, 
𝜇𝑠
′(785𝑛𝑚) = 7.0 𝑐𝑚−1, 𝐷𝐵 ≈ 1 × 10
−8 𝑐𝑚2/𝑠, and centrally stationed custom 
hinged structure for holding and swapping contrast elements (Figure 4.3). The 
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flow contrast was provided by a 6 mm side length solid cubical phantom, 
𝜇𝑎(785𝑛𝑚) = 0.05 𝑐𝑚
−1, 𝜇𝑠
′(785𝑛𝑚) = 7.0 𝑐𝑚−1, 𝛼𝐷𝐵 approximately three orders 
of magnitude lower than background as measured previously [125], submerged at 
2 mm depth on one side of the 60 mm × 60 mm FOV. Fluorescence, and inherently 
absorption, contrasts were created by tubes (5.9 mm outer diameter, 5.3 mm inner 
diameter; PRT00074, ClearTec Packaging, MO) filled with liquid phantom 
background and a varying concentration of ICG. They were submerged (one per 
each step) at 2 mm depth with concentrations in steps from 0.0625 – 4 µM in 
doubling fashion for a total of 8 steps (plus one step of 0 µM) on the opposite side 
of the FOV. This concentration range agrees with typical diffuse optical 
applications in the literature and includes the maximum ICG fluorescence signal 
(~1 μM) before it proceeds to decrease with further concentration increases. With 
reference to the coordinate system centered in the FOV (0, 0, 0) as the x-y plane 
on the surface at depth z  = 0 mm, the solid cube center was (-9.74, 0, 5.0) and 
tube center (12.3, …, 5.0; extending effectively indefinitely outside the FOV in the 
y direction).  
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Figure 4.3: Experimental setup for multimodal system testing. A liquid 
phantom background pervades a container centered around the camera FOV (blue 
dashed line). A custom holder also centered enables fast switching of flow (cubical 
solid phantom) and fluorescence/absorption (liquid-containing tubes) contrasts in 
the left and right regions, respectively. 
 
4.5 Data Acquisition Procedure 
 
Prior to data collection several preliminary tasks were performed. The 
container was placed in the camera FOV with the hinged structure centered. The 
liquid phantom background was then created with Intralipid, India ink, and distilled 
water as done in our earlier studies (see Chapter 3). This was used to fill the 
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container to a level 2 mm above the designated areas for cube and tube insertion. 
A single tube of 115 mm length was filled with the liquid phantom background 
solution and placed as designated in the hinged structure along with the solid 
phantom cube. The displacement of the surface level due to the added 
heterogeneities was negligible. Some liquid was removed temporarily to acquire a 
reference image of the heterogeneity layout as shown in Figure 4.4.  
 
 
Figure 4.4: Heterogeneity layout. A reference image of the positioning of flow 
(cube) and fluorescence (tube) contrasts prior to data collection. Data outside the 
dashed frame is within the FOV, but excluded from analysis. The surface level of 
the liquid phantom background was reduced only for this image. 
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After restoring the surface level and removing heterogeneities, the 785 nm 
laser source was applied. The galvo-mirror scan offsets to achieve a 9 × 9 grid of 
source positions were determined covering the 60 mm × 60 mm FOV. A set of 
images were acquired for post-analysis calculation of the source positions. This 
was repeated for the 830 nm laser along with verifying the scan settings and 
coverage area (Figure 4.5).  
 
 
Figure 4.5: Source-Detector layout for 785 and 830 nm. The 9 × 9 source 
(circles) and 41 × 41 detection (crosses) grids for (a) 785 nm and (b) 830 nm 
lasers. 
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Eight 115 mm length tubes were then filled with ICG in the following fashion. A 
base dye solution of 15.48 µM was created with 1.2 mg of ICG (MW: 775 g/mol) 
and 100 ml of the surplus liquid phantom background. The remaining surplus liquid 
phantom background, in a separate container, was brought up to the first step of 
0.0625 µM ICG concentration using the base dye solution. An aliquot was then 
taken to fill a single tube. The base dye solution was added again to the primary 
solution for 0.125 µM and an aliquot placed in the second tube. This was repeated 
to fill the remaining six tubes, up to 4 µM. 
The final preliminary objective was in establishing the exposure times for 
fluorescence and absorption measurements. The maximum concentration tube 
was placed in the structure along with the solid phantom cube. Exposure times 
were varied until the highest intensities were ~90% max (of 16-bit digitization; 
~59,000 counts). This increased the available signal while remaining below the 
level of pixel saturation. To accomplish this a program was written in MATLAB to 
mask and plot the intensity data in an SD range-delimited annulus for visualization. 
The flow exposure time was restricted in that it has an inherent relation with the 
flow dynamics – the value was selected based on our nc_scDCT study [100].  
Each step consisted of five unique system setups as shown in Table 4.1.  This 
row arrangement is maintained in actual data collection sequencing (Figure 4.6) 
to minimize transition time (e.g., switching filter and/or laser). An initial step not 
otherwise depicted consisted of the flow baseline step which included the 0 µM 
tube only (i.e., no cube present). Subsequent data collection then consisted of 
70 
 
acquiring data for each variation in tube concentration while the cube remained 
unhindered. 
 
Table 4.1: System collection parameters at a single step 
Target 
Exposure 
Time (ms) 
# Frames 
Frame 
Rate (fps) 
Filter 
Laser 
Source (nm) 
𝜂𝜇𝑎,𝑓𝑙 750 4 1.4 800LP 785 
𝜇𝑎(785 𝑛𝑚) 15 10 8 775BP 785 
𝐵𝐹𝐼(785 𝑛𝑚) 5 10 8 775BP 785 
𝐵𝐹𝐼(830 𝑛𝑚) 5 10 8 800LP 830 
𝜇𝑎(830 𝑛𝑚) 25 10 8 800LP 830 
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Figure 4.6: Data acquisition sequencing. The data collection is depicted at the 
top with a single complete step consisting of the simultaneous presence of the 
solid cube and a tube with 0 µM ICG. This is repeated for each step of increasing 
fluorescence up to the final step (solid cube plus 4 µM tube). The attached filters 
are identified as well as the corresponding source wavelengths, exposure times, 
and number of frames collected. 
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The data acquisition for an individual signal was automated through the 
complete set of 81 source positions using a customized LabVIEW program once 
the appropriate laser source and filters were attached. The automation was (for 
each position): set galvo-mirror offset values, signal galvo-mirror to move, wait 100 
ms, trigger camera, wait for exposure completion, wait for frame readout 
completion. The camera control program (open source µManager, Open Imaging) 
was set to acquire the appropriate number of images. 
To process the data, a 41 × 41 grid of logical detectors was identified to span 
the source grid area of the corresponding source (see Figure 4.5). Detectors were 
separated by 1.25 mm. Each source position was found by averaging the row and 
column indices for intensities greater than half max from the reference images 
collected at the beginning of the protocol. This is on the assumption that the 
intensity is roughly symmetric and falls away from the center in a radial (and 
exponential) manner. Ultimately, we end up with 136,161 possible SD 
arrangements. The actual data used in reconstructions was restricted by SD 
separation to limit noise while probing up to the requisite depth sensitivity of the 
contrast elements. With a sensitivity of ~1/2 SD separation, heterogeneity depth 
up to 8 mm, and increasing noise/decreasing signal at large SD, the SD range was 
limited to 16 mm. The lower end criteria excluded data close to the source (< 7 
mm) where the data tends to deviate from expectations as experienced in previous 
investigations. This SD range was kept consistent for all boundary data processing 
and reconstructions (e.g., flow, fluorescence, and absorption). 
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The post-analysis processing of data is shown in Figure 4.7. The processing 
overlaps in several ways such as dark correction, low-pass (Gaussian) filtering, 
and averaging data across frames. The flow and absorption data were smear 
corrected due to the order of the exposure time being near that of the frame 
transfer time (see Chapter 3). For all sets of information, the basic data was 
considered as that calculated in a 7 × 7 window. This was averaged over a 21 × 
21 block in the neighborhood of each effective detector. The resulting values were 
then averaged across the collected frames. A detector position was established as 
the center of its corresponding block. For flow, the reconstruction process requires 
an estimated 𝛼𝐷𝐵 at each SD pair which is determined by the semi-infinite based 
speckle contrast minimization (see Chapter 3). Calibration for flow was performed 
by applying calibration factors to boundary data as obtained from the baseline step 
where flow is homogeneous throughout (𝛼𝐷𝐵 ≅ 1 × 10
−8 cm2/s). The fluence 
boundary data for absorption was calibrated to the forward solution in NIRFAST of 
the homogeneous baseline step with known absorption coefficients. The 
fluorescent fluence boundary data was subtracted from the baseline step (i.e., no 
fluorescence) to remove the excitation signal. 
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Figure 4.7: Flow diagram of data processing. The diagram charts the path of 
data along various levels of processing for flow, fluorescence, and absorption. 
 
Absorption reconstructions are analogous to those of flow as outlined in 
Chapter 2.4. The substitution of 𝐺1 by Φ and setting 𝜏 = 0 provides the formally 
equivalent set of steps. These features are already provided within the FEM 
framework in NIRFAST [105, 110]. FEM fluorescence reconstructions also 
resemble those of absorption/PDE as can be seen by the similarity of the CW PDE 
(Equation 1.1) and coupled fluorescent diffusion equations (Equations 1.2 and 
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1.3). The formal definitions include comparable Robin boundary conditions, FEM 
discretization, and matrix equations where the source vector for the emission 
wavelength is expressed in terms of the (CW) excitation fluence 𝑆𝑓𝑙,𝑖 =
∫ 𝜓𝑖Φ𝑒𝑥𝑑ΩΩ , and the updating procedure includes both the excitation absorption 
𝛿𝜇𝑎,𝑒𝑥 and the fluorescence yield 𝛿𝜂𝜇𝑎,𝑓𝑙 as described in detail elsewhere [136] 
and is also already included in NIRFAST. 
The flow and absorption reconstructions used a mesh of [dimensions (mm): 70 
(H) × 70 (W) × 30 (D)] with 31,091 nodes at 1.05 mm node distance. The 
fluorescence had a mesh of reduced node numbers due to memory requirements. 
The corresponding mesh had [dimensions (mm): 70 (H) × 70 (W) × 30 (D)] with 
7,094 nodes at 2 mm node distance. In addition to SD range limits, edge regions 
were masked from SD pairs as shown in the outline in Figure 4.4. There were a 
total of 81 source and 1,681 detector positions used in all reconstructions with 
17,912/16,823 valid SD pairs for 785/830 nm sources. The average number of 
iterations and reconstruction times (minutes) for flow, fluorescence, and absorption 
are shown in Table 4.2. All reconstructions used a [20 20 20] pixel basis for the 
secondary mesh with 8000 nodes (used in calculating the Jacobian and update 
per iteration). Flow distributions are reported as nodal 𝑟𝐵𝐹 = 𝛼𝐷𝐵/𝛼𝐷𝐵,0 where 
𝛼𝐷𝐵,0 are the nodal values from the 0 µM tube, absent solid cube step. 
Fluorescence results are reported as nodal 𝑟𝜂𝜇𝑎,𝑓𝑙 = 𝜂𝜇𝑎,𝑓𝑙/(𝜂𝜇𝑎,𝑓𝑙)0 where 
(𝜂𝜇𝑎,𝑓𝑙)0 is the baseline step of 0.0625 µM tube with cube present. Absorption 
results are reported as actual recovered nodal values.  
  
76 
 
Table 4.2: Reconstruction iterations and times 
Reconstruction 
# Iterations 
Reconstruction Time 
(minutes) 
785 nm 830 nm 785 nm 830 nm 
Flow 13.7 ± 0.8 13.1 ± 0.3 59.4 ± 2.8 52.9 ± 4.0 
Fluorescence 50.6 ± 6.9 - 704 ± 96 - 
Absorption 10.0 ± 3.8 11.2 ± 3.7 45.7 ± 17.0 46.1 ± 14.5 
 
4.6 Results 
 
The fluorescence distributions recovered at each step of varying ICG 
concentration are shown in Figure 4.8. The tube shown was separated from 
background by a threshold of three standard deviations above the mean. The 
detection and localization capabilities are evident with the tube clearly separated 
from the background and in the region expected. The characterization of the tube 
shape is distorted in appearance but has similarity to a tube with the proper 
orientation. This inadequacy is due in part to the lower density mesh used in 
fluorescence reconstructions. The characterization of relative fluorescence 
changes involved normalization of the extracted heterogeneity average 
fluorescence per step to the middle of the tested range (1 µM) as shown in Figure 
4.9. These values are compared to the expected values with good agreement. The 
larger deviations at higher concentrations is likely caused by the self-quenching 
and diminished signal of ICG at concentrations greater than 1-2 µM resulting in 
underestimations in comparison with the strict trend used. Additionally, 
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inaccuracies in the preparation of ICG may result in the absolute concentrations 
being lower/higher than expected. Extracting small amounts of solid ICG for 
placement in the aqueous base solution created an uncertainty in the mass with 
true value in the range of 1.2 ± 0.2 mg. Due to the instability of ICG in water, 
creating a large base solution for storage and reuse was not feasible. 
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Figure 4.8: Recovered fluorescence images. The heterogeneity as recovered 
by fluorescence distributions for each step of ICG variation. 
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Figure 4.9: Recovered fluorescence changes. The heterogeneity average 
fluorescence as recovered by fluorescence distributions for each step of ICG 
variation in comparison with the expected changes (solid line). 
 
The heterogeneity as extracted by absorption coefficient distributions are 
shown for 785 nm and 830 nm in Figures 4.10 and 4.11, respectively. The 
background and heterogeneity were separated by a threshold of three standard 
deviations above the mean. The heterogeneity detection and localization with the 
absorption coefficients were quite evident for 785 nm. Corresponding tube shapes 
and orientations were also in agreement with the known situation. These 
characterizations increasingly trended towards the tube properties with increasing 
concentration. At the lowest concentrations (e.g., < 0.25 µM) the tube was difficult 
to separate from the background with some noticeable erroneous inclusions. The 
830 nm results have artifacts that are obfuscating the recovery of the true tube 
data. However, at higher concentrations (e.g., > 1 µM) the increasing absorption 
dominates and the conclusions coincide with that for 785 nm absorption 
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coefficients. Using the threshold-extracted heterogeneity at each step, nodal 
absorption coefficients were averaged and their change with ICG concentration is 
shown in Figure 4.12. There is a 320% increase in 785 nm absorption over the 
steps. The 830 nm absorption trend is inconclusive due to artifacts in the lower 
ranges. 
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Figure 4.10: Recovered 785 nm absorption. The 785 nm absorption coefficient 
distributions are shown for each step of ICG variation for the extracted 
heterogeneity. 
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Figure 4.11: Recovered 830 nm absorption. The 830 nm absorption coefficient 
distributions are shown for each step of ICG variation for the extracted 
heterogeneity. 
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Figure 4.12: Recovered absorption coefficient changes. The nodal average of 
absorption coefficients as recovered from the threshold-extracted heterogeneity at 
each step. 
 
Further characterization includes the tube depth and lateral position as shown 
in Figure 4.13 for the fluorescence and absorption coefficient extracted 
heterogeneities at each step. The depth is calculated as the z-coordinate of the 
center of mass (nodal weighted fluorescence or absorption coefficient). The lateral 
position similarly is by the x-coordinate of the center of mass. As the tube extends 
outside the FOV, the y-coordinate is not specified but instead the agreement was 
visualized in Figures 4.8, 4.10, and 4.11. The tube depth was most successfully 
recovered by the fluorescence signal with an average percentage error of 41% 
whereas 785 nm absorption was 74% error (830 nm data insufficient). The 
increasing signal with fluorescence did not correct the depth estimate. This is due 
in part to the sampling density and that ICG (MW 775 g/mol) may have 
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preferentially accumulated at the bottom of the tube (primarily water: MW ~18 
g/mol). The lateral positioning did, however, show a gradual improvement with 
concentration. 
 
 
Figure 4.13: Characterized tube properties. The (a) tube depth (center of mass 
z-coordinate) and (b) lateral position (center of mass x-coordinate) are shown 
based on the recovered fluorescence and absorption coefficients. The actual value 
is provided by a solid line for comparison. 
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In the case of flow, we expect the reconstructed heterogeneity to resemble a 
cube and present with low flow values with respect to the background. The flow 
heterogeneity as extracted by half-minimum threshold is shown for 785 nm and 
830 nm in Figures 4.14 and 4.15, respectively. The cube is detected and localized 
in the appropriate region by both wavelengths at low concentrations of ICG. A 
noticeable disturbance in the tube region arises at ~0.25 µM for 785 nm and ~1 
µM for 830 nm. The size of the disturbance increases with the graduation of ICG 
concentration. The derived cube center of mass, averaged 𝑟𝐵𝐹, and average side 
lengths are shown in Figures 4.16 and 4.17. This data excludes the region of 
disturbance and only pertains to the cube properties. The x and y coordinates were 
near to the true values with offsets of: 1.7 ± 0.46, 1.7 ± 0.38 mm and 0.67 ± 0.24, 
0.52 ± 0.22 mm, respectively for 785/830 nm. This coincides with the square 
appearance of the upper portion of the recovered cube shape. Depth recovery for 
785/830 nm was off by 4.0 ± 0.09, 3.8 ± 0.06 mm over all cases as reflected in the 
z center of mass coordinate and recovered shape. The threshold chosen was 
based on previous studies as well as the best recovery of the cube as judged 
across all steps. Modifying the threshold and increasing the sampling density in 
the cube region can improve characterization. The heterogeneity 𝑟𝐵𝐹 was 
consistent throughout all steps with 785 nm (0.41 ± 0.05) higher on average in 
comparison with 830 nm (0.31 ± 0.07). Both values dropped after the first step 
suggesting some vestiges of motion lingered from the early setup stages. As all 
relative flow values depend on the first step, it is expected that the difference 
between the recovered flow in the first step from both wavelengths persisted 
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through the remaining steps once the phantom had stabilized. The relative flow 
values agreed with previous measurements. The last metric characterized was the 
average side length. While 830 nm exhibited a nearly constant recovered side 
length (5.0 ± 0.55 mm), 785 nm (3.9 ± 1.2 mm) had strong influences due to the 
ICG presence (> ~0.25 µM). The inaccuracy in depth and corresponding “depth 
side length” contribution is likely the cause of both wavelengths’ underestimation 
of the average side length in all cases. 
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Figure 4.14: Recovered 785 nm flow. The heterogeneity as recovered by flow 
distributions with a half-min threshold for extraction over all steps. 
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Figure 4.15: Recovered 830 nm flow. The heterogeneity as recovered by flow 
distributions with a half-min threshold for extraction over all steps. 
 
89 
 
 
Figure 4.16: Cube location. The results of the recovered cube center of mass 
coordinates from the extracted flow heterogeneity at each step. The 0 μM step is 
represented as 0.01 μM for visualization on the log scale. 
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Figure 4.17: Cube characteristics. The (a) average rBF and (b) average side 
length from the heterogeneity extracted at each step from flow distributions. The 0 
μM step is represented as 0.01 μM for visualization on the log scale. 
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4.7 Observations and Limitations 
 
The results of this study provide insight into the feasibility of applying this 
prototype multimodal diffuse flow and fluorescence imaging system into recovering 
a combined tomographical set of parameters. The instrumentation possesses all 
the features desired in the outset, namely noncontact, noninvasive, translational 
potential, flexible design, reflectance mode, and important flow and fluorescence 
endpoint information. The incorporation of the novel nc_scDCT design provided 
enhanced sampling density and SD patterns over previous implementations. The 
addition of diffuse optical tomography techniques during experimentation has 
given prescience to problematic circumstances that may occur under application 
of this new device. Explication into the outcomes, reconciliations, and limitations 
will elucidate these findings. 
There are two major time obstructions in this study, to be evaluated on a case 
by case basis in future studies, which are the stepwise and total experimentation 
times. For an individual step there is a tradeoff regarding bottleneck factors 
including the maximum camera frame rate, long fluorescence exposure time, 
source position number/density, and frame number (see Figure 4.5 and Table 
4.1). The camera frame rate can be improved by camera selection and binning. To 
retain a full set of pixel information we did not use binning. The fluorescence 
exposure time is an order greater than that used for absorption and two orders for 
flow. As the fluorescence signal is generally only a small fraction of the original 
signal one may seek to maximize filter quality, fluorescence concentrations, 
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excitation intensity, camera sensitivity, and use a fluorescent agent with greater 
quantum yield. The signal increase with fluorescence concentration may peak as 
is the case with ICG around 1-2 µM. An increase in source positions can probe a 
greater amount of detail from the sample. As the purpose of this study was to 
combine detection and characterization, we selected a distributed source pattern 
that included both homogeneous and heterogeneous regions. The data from each 
source must be taken independently due to the point-like source and detection 
models incorporated. Too many source positions may result in subject movement 
artifacts, physiological changes, and computational overhead. These time-
consuming options are then protracted by the number of frames collected. The two 
sources as employed in this study add a multiplicative layer to this envelope. The 
total experimentation time is then, under the assumption that each step is identical 
in collection, scaled by the number of overall steps. For example, increasing the 
number of concentrations tested would greatly increase the total duration. The 
upper limit was the stability of ICG in aqueous solutions at approximately 6 hours. 
In clinical studies, the stability of ICG in plasma and whole blood is not a significant 
factor but the clearance rate and desired temporal resolution will intimate the 
governing constraints. 
The most observable deviation from expectations was the disturbance of flow 
recovery with increasing ICG concentrations (see Figures 4.14 and 4.15). The 
source of this influence is not allocated to the fluorescence signal which is both 
filtered and inherently significantly weaker than the excitation light. The 
accompanied absorption coefficient changes are conversely known to cause 
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errors in diffuse correlation flow analysis [112, 118]. Specifically, an 
underestimation of the absorption coefficient results in an underestimation in the 
flow. As the absorption coefficient in the ICG tube is continually increasing (see 
Figure 4.12) it is expected that our use of the background value for fluorescence 
reconstructions is leading to an underestimate in flow. Therefore, the ICG region 
is promoting a drop in flow boundary data that is not due to any actual flow 
presence. As the referenced results analyze DCS rather than scDCS, typical 
parameters were used to show they are similarly affected (Figure 4.18). In most 
blood flow studies involving diffuse optics the relative blood flow over time is 
unchanged regardless of the absorption coefficient value. However, these are with 
the expectation that there are no changes during the experiment/interval. In the 
case of changing ICG the absorption coefficient is not static and therefore can 
introduce uncertainties in the results. The extent of influence depends both on the 
level of absorption coefficient change as well as the measurement in question. One 
must note the potential implications both on spatial and temporal heterogeneities. 
In this study, we only looked at flow relative to an otherwise homogeneous 
absorption background and with the flow and ICG in separate regions. 
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Figure 4.18: Comparison of DCS and scDCS errors with absorption 
coefficient. The percentage errors between the actual and recovered blood flow 
index by DCS (g2) and scDCS (𝐾2; multiple exposure times) in typical 
circumstances over increasingly underestimated absorption coefficients. In this 
study, a 5 ms exposure time for flow corresponds to the region between the red 
and blue solid lines.  
 
To minimize the absorption change influence on flow results, we consider 
several counteractions by means of system modification, context leveraging, or 
measurement protocol adjustment. Two system additions were integrated in the 
current study: adding a second laser source (830 nm) at a different wavelength 
from that used to induce a strong fluorescent signal (785 nm), and monitoring 𝜇𝑎 
changes with DOT. When selecting a separate source for flow we enlist a 
wavelength outside of the maximum region of ICG absorption. From Figures 4.14 
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– 4.17, the 830 nm with a lower position in the ICG excitation spectrum (Figure 
4.2) did offer an improvement in flow results. A source on the lower end, around 
660 nm, is another option. The accompanying optical properties will, however, 
inhibit in other ways including increased scattering at lower wavelengths and 
increases in chromophore absorption at both ends of the NIR spectrum (Figure 
1.1). In either case, there will be two laser sources required which can greatly 
increase data acquisition time as described earlier. We also added DOT to append 
our parameter set with the absorption changes. From this we found a large 
absorption change (Figure 4.12). In practice, by reviewing this concurrent 
information post-measurement volumes of large absorption change may be 
marked unreliable and removed from further analysis. We would first need to select 
a threshold for what constitutes a large absorption change (e.g., use estimates for 
DCS [118] or perform equivalent scDCS analysis) as well as remove all flow 
boundary data that is sensitive to the region(s) effected. In real tissues this solution 
could become intractable due to heterogeneous distributions, DOT measurement 
uncertainties, and the ability to perform reconstruction adequately with remaining 
data. In such circumstances the flow data would be completely disregarded. The 
ability to add CW DOT is straightforward with the combined system as the laser 
source and filter are already implemented. There is, of course, the additional 
overhead of collecting the DOT data which can inhibit the temporal resolution. 
System modifications may not be necessary if, by experience, we already know 
the ICG absorption to fluctuate only within a small range (as the absorption 
contrast itself is a popular use of ICG). In practice, the fluorescence is usually 
96 
 
examined in relative fashion and can be subject to pH and tissue microenvironment 
variations and therefore is in general, by itself, an insufficient indicator of feasibility. 
Other fluorescent agents than ICG require individual examination. Finally, one 
might simply acquiesce to the possibility of unresolvable absorption interference 
and restrict flow measurements to pre-fluorescence injection and post-clearance 
(or the phantom equivalent). We note here for completeness that the reduced 
scattering coefficient has an even greater influence on flow recovery than the 
absorption coefficient, but that there is no expected introduction of significant 
scattering changes due to ICG [135]. An additional consideration is the red-shifting 
of ICG absorption in plasma as opposed to the aqueous solution tested (Figure 
4.2). 
The computing resources for processing the fluorescence data surpassed that 
available for our reconstruction computer (2.80 GHz i7-7700HQ, 32.0 GB memory) 
requiring a mesh of decreased density. This is primarily due to the implementation 
building a pre- and current-iteration Jacobian which collectively has greater 
memory requirements than the standard CW DOT or flow reconstructions. For the 
standard reconstructions a conjugate gradient alternative is available to reduce 
memory expense with a longer reconstruction time but was not implemented for 
fluorescence at the time of this study. It is technically simple to convert a mesh 
created for flow to that for absorption and fluorescence given they are all in 
MATLAB and can be done in future studies to have a directly comparable set of 
mesh information. Use of supercomputing resources, Jacobian subsets, task 
paralellization, GPU-based solvers, and fewer SD combinations can help relax 
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overhead on mesh agreement and reduce computation times [137, 138]. The valid 
SD combinations depend on both the source positions as outlined earlier as well 
as the defined detectors. When selecting a detector grid we avoid touching (side-
by-side) spacings which contribute marginal information in terms of the tradeoff for 
spatial sampling. Increasing the detector number extends the reconstruction time 
and necessary resources. 
We conclude that with this prototype we illustrated the ability to extract flow 
and fluorescence, but that the situation in practice is complex and requires care in 
properly setting up, acquiring, and consuming the information. In the next chapter 
we look towards the future and areas of improvement. 
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CHAPTER 5 STUDY SUMMARY, LIMITATIONS, AND FUTURE 
PERSPECTIVES 
 
5.1 Study Summary 
 
In this dissertation, I presented a progression of continuously advancing diffuse 
optical devices towards the noncontact reflectance imaging of 3D flow and 
fluorescence distributions in deep tissues/phantoms. The initial ncDCT system 
with its mechanical scanning apparatus, complex boundary acquisition methods, 
and new FEM flow reconstruction technique provided a useful first generation of 
completely noncontact flow imaging capability. This instrument was applied to a 
small animal aggressive breast tumor model highlighting the potential for 
longitudinal reflectance flow imaging for visualization and relative quantification of 
cancerous microvascular developments. The successor scDCT system 
demonstrated a movement to CCD-based light detection for improved spatial and 
temporal detector sampling, a uniquely requisite smear correction, and speckle 
contrast flow measurement. Testing illustrated a sensitivity to the presence of high 
flow contrast and subsequent characterization. The final multimodal nc_scDCT 
and DFT prototype made its province with the best features of both the previous 
systems along with related noncontact scDCT developments. With this fully 
noncontact source and detector arrangement and filter set, high contrast flow and 
fluorescent heterogeneities were identified and characterized in tissue-like 
phantoms. 
The novel nc_scDCT/DFT system embodies all the desirables proposed in the 
outset. The potential for new cancer studies are extensive, especially by coupling 
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the realm of nanoparticles. For example, nanoparticles may be repletely tagged 
and monitored as drug carrying vehicles or, alternatively, designed to improve 
tumor targeting for the proper localization of the fluorescence signal itself. As the 
vasculature is the most common route of conveyance for transporting agents 
throughout the tissues (as opposed to site injection for example), analyzing 
corresponding blood flow variations can offer new insights into the underlying 
factors contributing to nanoparticle success or failure. With the new instrument we 
can now build upon the already established advantages of the diffuse optical 
methods in cancer imaging. 
My major contributions to the studies herein are as follows: 
ncDCT. I had primarily a supporting role in the development of ncDCS/ncDCT 
instrumentation, source and detector alignment on complex boundaries, and 
ncDCT application to breast tumors. My major contributions in respect to ncDCT 
concern its application to small animal tumors. I performed all animal ncDCT 
measurements, image reconstructions, and analysis (Chapter 2.6). I was able to 
find average tumor flow changes and volumes after a four-day gap for a mouse 
with two palpable tumors. The localization and separation of tumor tissues relative 
to healthy tissues was also described along with numerous observations for 
enhancing future studies of a similar nature. 
scDCT. Forwarding the transition from APD to CCD detection I derived the 
relationship between speckle contrast and the semi-infinite form of the electric field 
temporal autocorrelation function as modeled by the correlation diffusion equation 
(Equations 3.1 – 3.9; Chapter 3.3). I also worked with a vendor to obtain a 
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customized optical switch to fulfill our requirements within the constraints and 
wrote the LabVIEW program to operate it in sequencing light around the FOV for 
phantom experimentation. Through meeting Cancer Nanotechnology Training 
Center (CNTC) fellowship obligations (e.g., extra coursework, meetings, seminars, 
clinical experience, reports, outreach activities, and journal club attendance), I 
made available the funding for hardware (i.e., optical switch, zoom lens, DAQ 
board, etc.), software (e.g., SolidWorks and TracePro), and supplies with $25,775 
funding, $30,000 stipend, and $3,200 travel funding. 
nc_scDCT/DFT. I supplemented previous scDCT/nc_scDCT system designs 
with the necessary stackable tubes for combining the cross-polarizer and a set of 
filters to instantiate a multimodal nc_scDCT/DFT prototype (Chapter 4). I designed 
a flow and fluorescence experiment for verifying its proper operation. This included 
building a custom hinged holder from a clear acrylic sheet. An experimental 
protocol was carefully formed to exhibit the flow and fluorescence recovery within 
the constraints of source/detector number tradeoff and arrangement, ROI 
coverage, exposure time durations, frame averaging, and the number of steps to 
evaluate. Programming was added to coordinate source laser position scanning 
with varied exposure times and camera triggering. I performed all measurements, 
analysis, and summarization of the flow and fluorescence detection and 
characterizations. The CNTC fellowship also supported funding of components in 
this study including the galvo-mirror, filters, lenses, alternative test setups 
(involving filter wheels and lenses), and other related supplies. 
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Other. My other significant contributions include the assistance in writing, 
editing, and/or reviewing manuscripts, grant proposals, and presentations. I have 
been involved in many other in vivo studies including clinical measurements of 
human head and neck tumors prior to and during radiation therapy, breast tumor 
imaging, peripheral arterial revascularization surgery, electrical stimulation blood 
flow response, mouse leg cuff occlusion, and human subject orthostatic tolerance 
by cardiovascular response to antigravity treadmill and bed tilting. 
 
5.2 Study Limitations and Future Perspectives 
 
Flow acquisition improvements. Acquiring flow by means of speckle 
contrast from an image at a specific exposure time has its encumberments. 
Specifically, the exposure time is minimally flexible due to its relationship with flow, 
the aperture (f/#) is related to the smallest speckle size and Nyquist sampling, and 
the laser source must possess a long-coherence length. These factors combined 
limit the intensity. Utilizing the EM gain supplied by our highly sensitive EMCCD 
camera should enhance the available signal and reduce the influences of noise 
and promote repeatability. A camera with a greater frame rate will allow for more 
frame averaging. The type of noise to be minimized will dictate the experienced 
benefits of either such solutions. 
Detection and characterization tradeoff. The testing of the multimodal 
imager prioritized neither heterogeneity detection or characterization. This mixed 
approach creates a situation where neither objective is optimized but rather a 
balance is obtained. The accuracy of object characterization can be improved by 
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taking more measurements near the heterogeneity such that most of the signals 
detected have interacted with it. However, in practice we may not know where such 
disturbances exist. As such, a spatially distributed set of SD pairs can be first 
utilized to localize the object with follow up imaging of increased sampling density 
in the target ROI’s. 
Device automation. The prototype nc_scDCT/DFT did not employ full 
automation. The extension thereof is expected to be straightforward with mostly 
time overhead. The filters can be exchanged dynamically with an appropriate 
motorized filter wheel for 2-inch diameter lenses. The laser sources can be 
alternated by the optical switch. The optical switch was not used during the current 
study so as to maximize flow signal. Combining the switch with the aforementioned 
flow signal compensations can make this feasible. Both the filter wheel and optical 
switch will incur some programming support for proper operation. Ultimately, this 
will provide the most robust system as originally conceptualized. 
Flow reconstruction. The current flow reconstruction technique though useful 
couples the blood flow index reconstruction to the absorption coefficient in an 
undesirable fashion. It is anticipated that deriving an adjoint Jacobian formulation 
and corresponding update for flow specifically can improve flow imaging. This will 
not obviate the concerns regarding absorption changes. As is evident from the 
adjoint formulation, the absorption and reduced scattering coefficients continue to 
contribute to the sensitivity. Further investigation into L-curve analysis may also 
prove beneficial in optimizing selection of the reconstruction iteration to clarify the 
adequacy of assuming this method for the combined total absorption.  
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APPENDIX: GLOSSARY 
 
 
Notations/ 
Terms 
Description 
𝛼 Ratio of dynamic to total scatterers 
𝛼𝐷𝐵 Blood flow index (𝐵𝐹𝐼) 
𝛽 Factor related to speckle and collection optics 
𝜖𝑒𝑥 Fluorophore extinction coefficient 
𝜂 Fluorescence quantum yield 
𝜂𝜇𝑎,𝑓𝑙 Fluorescent yield 
𝜆 Wavelength 
𝜇𝑎 Absorption coefficient 
𝜇𝑎,𝑒𝑥 Absorption coefficient (excitation) 
𝜇𝑎,𝑓𝑙 Absorption coefficient (emission) 
𝜇𝑎
𝑡𝑜𝑡𝑎𝑙 Total absorption coefficient 
𝜇𝑠
′  Reduced scattering coefficient 
𝜈 Speed of light in tissue 
𝜌 Source-detector separation 
𝜏 Correlation delay time 
Φ Photon fluence 
Φ𝑒𝑥 Photon fluence (excitation) 
〈∆𝑟2(𝜏)〉 Mean-square scatterer displacement 
𝐵𝐹𝐼 Blood flow index (𝛼𝐷𝐵) 
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𝐷 Photon diffusion coefficient 
𝐷𝑒𝑥 Photon diffusion coefficient (excitation) 
𝐷𝑓𝑙 Photon diffusion coefficient (emission) 
𝐷𝐵 Scatterer diffusion coefficient 
𝐺1 Unnormalized temporal electric field autocorrelation function 
𝑔1 Normalized temporal electric field autocorrelation function 
𝐺2 Unnormalized temporal intensity autocorrelation function 
𝑔2 Normalized temporal intensity autocorrelation function 
𝐼 Intensity 
𝑘0 Wavenumber 
𝐾 Speckle contrast 
𝑛 Index of refraction 
[𝑁] Fluorophore concentration 
𝒓 Position vector 
𝑟𝐵𝐹 Relative blood flow 
𝑅𝑒𝑓𝑓 Effective reflection coefficient 
𝑇 Exposure time 
CW Continuous wave 
DCS/T Diffuse correlation spectroscopy/tomography 
DFS/T Diffuse fluorescence spectroscopy/tomography 
DOS/T Diffuse optical spectroscopy/tomography 
fps Frames per second 
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ICG Indocyanine green 
ncDCS/T Noncontact diffuse correlation spectroscopy/tomography 
nc_scDCT Noncontact speckle contrast diffuse correlation tomography 
NIR Near infrared 
scDCS/T Speckle contrast diffuse correlation spectroscopy/tomography 
SD Source-Detector separation 
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